Bibliography in fetal ultrasound

Demo

Demo

With this bibliographical review, we aim to offer obstetric ultrasound practitioners an original tool to aid in scientific monitoring, positioned between the conventional abstract and the often lengthy and time-consuming full reading of the original article.

This hybrid format ensures substantial time savings by enabling the rapid and targeted identification of publications that, based on their content, warrant an in-depth reading.

Transposition of the Great Arteries

Overview

Prenatal diagnosis of Transposition of the Great Arteries (TGA), a significant congenital heart defect (CHD) characterized by ventriculoarterial discordance and atrioventricular concordance with a parallel relationship of the great arteries, is crucial for improving postnatal outcomes. TGA accounts for 5% to 8% of fetuses or infants with CHD and is a common cyanotic heart defect. Despite advancements in prenatal ultrasound screening, TGA is commonly underdiagnosed in utero, with prenatal detection rates often remaining below 50%. This low detection rate has been attributed to technical difficulties in consistently imaging the outflow tracts using standard obstetric ultrasonography.

Accurate prenatal diagnosis offers several benefits, including facilitating effective prenatal counseling, enabling early postnatal intervention and treatment, enhancing perinatal decision-making and delivery planning, and providing for optimal management of the unique transitional physiology of affected newborns. Delays in diagnosis and treatment can lead to rapid hemodynamic compromise, significant morbidity, and even death. Studies suggest that prenatal diagnosis of TGA can reduce neonatal morbidity and mortality. Furthermore, it may lead to earlier balloon atrial septostomy (BAS) and less need for mechanical ventilation pre-operatively. While mortality rates between pre- and postnatally diagnosed patients may not always show statistical significance due to overall low mortality in modern cardiac centers, prenatal diagnosis may confer long-term benefits, potentially minimizing pre-operative morbidity and positively impacting neurodevelopmental outcomes.

Several ultrasound techniques and markers are employed for the prenatal diagnosis of TGA:

  • Systematic Visualization of Outflow Tracts with 4D Ultrasonography and STIC: Spatiotemporal image correlation (STIC) is a technological advancement in ultrasonographic imaging that allows dynamic multiplanar slicing and surface rendering of the fetal heart. A systematic approach to image the outflow tracts from volume data sets acquired with STIC has been developed, and the addition of color and power Doppler imaging enhances the dynamic display of rendered views with minimal manipulation. This approach, involving volume data set acquisition followed by systematic imaging algorithms for gray scale, color, or power Doppler, may reduce operator dependency. In TGA, STIC can systematically visualize the abnormal parallel relationship of the outflow tracts, contrasting with the normal crisscrossing of the great arteries. Volume acquisition typically requires only clear visualization of the apical 4-chamber view for a short duration.
  • The “Misnomer Three Vessels” View: The three-vessel view (3VV) is usually recommended for detecting abnormal relationships of the great arteries and is generally used to screen for TGA. In a normal fetus, the pulmonary artery, aorta, and superior vena cava are arranged in a straight line. However, in fetuses with TGA, a normal three-vessel view cannot be visualized because the great arteries are not aligned, with the aorta located more anteriorly. The “misnomer three vessels” sign, where only two vessels (aorta and superior vena cava) are identified in the three vessels and trachea view (3VT) instead of three (pulmonary artery, aorta, and superior vena cava), provides a strong suspicion of TGA.
  • Parallel Outflow Tracts: The ventricular outflow tract view is crucial to demonstrate the discordant ventriculoarterial connection. In TGA, the right and left ventricular outflow tracts are parallel to each other and are thus imaged in a single (sagittal) plane. Color Doppler imaging can convincingly demonstrate this parallel relationship. Identifying the origin of each great artery, with the aorta arising from the right ventricle and the pulmonary artery arising from the left ventricle, is a key marker.
  • The “I-shaped” Sign in the Upper Mediastinum: This novel ultrasound marker is characterized by an elongated aortic arch running across the chest in an anteroposterior direction, forming an ‘I’-shape in the three vessels and trachea view. It is often easier to visualize than the long-axis view of the left ventricle. The detection of this extremely long, I-shaped vessel should raise suspicion of cardiac anomaly, especially dTGA. The I-shaped sign is considered a sensitive, specific, and simple method for detecting dTGA during fetal echocardiography. In normal hearts, the great vessel arising from the anterior right ventricle typically shows a convexity to the left, whereas in TGA, the aorta arising from the anterior ventricle shows an abnormal convexity to the right.
  • Abnormal Right Convexity of the Aorta: An abnormal right convexity of the great vessel arising from the anterior ventricle (aorta) in the 3VT view is another potential marker for TGA. In normal fetuses, the pulmonary artery arising from the anterior right ventricle shows a leftward convexity. The presence of only two vessels (SVC and aorta with rightward convexity) in the so-called 3VT view can be indicative of TGA.
  • The “Baby Bird’s Beak Image”: Assessing the left ventricular outflow tract (LVOT) to determine if an arch or a bifurcation arises from it is important. In TGA, the pulmonary artery arises from the LVOT, and the image of its bifurcation may resemble the head of a baby bird with an open beak, known as the “baby bird’s beak image”.
  • Sono-AVC (Sonographically-based Volume Computer-aided Analysis): This software, applied to 4D STIC cardiac volumes, enables automatic retrieval of the abnormal ventricular outflow tracts in fetuses with TGA. It can facilitate the identification of abnormal atrioventricular connections from a standard four-chamber view.

 

The detection rate of TGA by standard obstetric ultrasonographic evaluation is historically low. However, the prenatal diagnosis rate has shown improvement over time, although it still often remains below 50%. Factors influencing detection include the experience of the examiner, the gestational age at examination, and the incorporation of specific views like the outflow tract view (OTV) and the three vessels and trachea view into routine screening protocols. Recommendations from international ultrasound societies now emphasize the importance of the OTV as an integral part of fetal cardiac screening.

TGA can occur as an isolated anomaly or in association with other cardiac and extracardiac malformations. When associated with other cardiac anomalies visible on the four-chamber view (e.g., ventricular septal defect, abnormal cardiac axis, chamber size discrepancy), prenatal detection may be easier compared to simple TGA with a normal four-chamber view. Chromosomal and extracardiac anomalies are relatively rare in isolated TGA, but their presence warrants consideration. TGA has been linked to maternal pre-gestational diabetes, exposure to pesticides, and first-trimester retinoic acid use.

Studies on prenatal diagnosis of TGA often have limitations such as being retrospective, single-center studies with relatively small sample sizes. Further prospective studies are needed to validate novel markers like the I-shaped sign and the rightward convexity of the aorta. Ongoing research continues to explore the long-term benefits of prenatal diagnosis on functional and neurodevelopmental outcomes. The focus should be on improving education and consistent performance and interpretation of key ultrasound views to increase prenatal detection rates of this critical CHD. A multidisciplinary approach to diagnosis and management, along with improved secondary and tertiary prevention systems for birth defects, is essential for optimizing outcomes for fetuses with TGA.

Bibliographie

This report describes the ultrasonographic findings of Transposition of the Great Arteries (TGA) based on a systematic approach using 4-dimensional echocardiography with Spatiotemporal Image Correlation (STIC). STIC is presented as a recent technological advance in ultrasonographic imaging that allows for dynamic multiplanar slicing and surface rendering of the fetal heart. A previously developed technique for systematically visualizing the outflow tracts from volume data sets acquired with STIC is highlighted. The addition of color and power Doppler imaging to STIC technology enables the dynamic display of rendered views of the outflow tracts with minimal manipulation of the volume data set.

The prenatal diagnosis of TGA is associated with a significant reduction in both preoperative and postoperative mortality, a decrease in the rate of metabolic acidosis and multiorgan failure during the neonatal period, reduced need for ventilatory support, and shorter hospitalization time. Despite these benefits, prenatal detection rates for TGA have historically been low. Reasons for this low detection include the absence of risk factors to identify a target population for screening and the need to systematically examine the outflow tracts to establish the diagnosis. Although scientific societies recommend extending the basic fetal cardiac examination to include visualization of the outflow tracts, this remains a technical challenge for many sonographers.

The authors propose that a 4-dimensional volume data set acquisition followed by a systematic approach to image the outflow tracts may reduce the operator dependency of prenatal ultrasonography. While volume acquisition remains operator-dependent, once a good-quality volume data set is acquired, the outflow tracts can be systematically imaged using developed algorithms for gray scale, color, or power Doppler imaging. It is anticipated that these algorithms may eventually become automated by computer software (automated multiplanar imaging).

The objective of this report was to describe the ultrasonographic findings of TGA using this systematic 4-dimensional echocardiography with STIC approach. A case report is presented involving a 43-year-old patient at 20 3/7 weeks’ gestation with a suspected heart anomaly on 2-dimensional ultrasonography. The examination aimed to verify whether the authors’ previously described techniques for systematic visualization of the outflow tracts using 4-dimensional volume data sets acquired by STIC could be used to examine the heart [6, 3–5].

Two-dimensional ultrasonography in the case revealed a normal 4-chamber view. However, visualization of the outflow tracts showed the great arteries exiting the ventricular chambers in parallel.

Volume data sets were acquired using STIC with a Voluson 730 Expert ultrasound system. Both gray scale ultrasonography and gray scale plus power Doppler imaging were used during acquisition, which lasted between 7.5 and 15 seconds with an acquisition angle of 25° to 35°.

A 4-step approach to evaluate the fetal heart using multiplanar display images was applied to the 4-dimensional volume data set. TGA was demonstrated in steps 3 and 4. Rotation of the volume data set around the y-axis (step 3) allowed visualization of two vessels leaving the ventricular chambers in parallel. Positioning the reference dot at the center of the vessel leaving the left ventricle (step 4) and examining the sagittal orthogonal view confirmed that this vessel was actually the pulmonary artery.

Volume-rendered power Doppler images of the outflow tracts in a normal case showed crisscrossing of the great arteries, whereas in the case with TGA, the great vessels were visualized leaving the ventricular chambers in parallel. The technique used to obtain these rendered images is illustrated in Figure 5.

The findings were independently confirmed by fetal and neonatal echocardiography.

The discussion section highlights that TGA is a common cyanotic congenital heart defect, occurring in approximately 0.2 to 0.4 per 1000 live births and representing 2.5% to 5% of all congenital heart defects. In TGA, the pulmonary artery arises from the left ventricle, and the aorta arises from the right ventricle. Associated anomalies can include ventricular septal defects, pulmonary stenosis, and coarctation of the aorta. Postnatal oxygenation depends on mixing of blood through a patent foramen ovale, ductus arteriosus, or a ventricular septal defect due to the parallel functioning of the ventricles.

Prenatal diagnosis of TGA is linked to a reduction in perinatal morbidity and mortality. Studies have shown that prenatal diagnosis is associated with a reduced need for mechanical ventilation, a decreased frequency of metabolic acidosis and multiorgan failure, shorter hospitalization stays, and decreased preoperative and postoperative mortality. The definitive treatment for TGA is the “arterial switch” operation, with surgical mortality potentially as low as 2%. Preoperative mortality is therefore a significant concern.

This report demonstrates that 4-dimensional gray scale and power Doppler STIC can be used to systematically visualize the abnormal relationship of the outflow tracts in fetuses with TGA. Volume acquisition requires only clear visualization of the apical 4-chamber view during 2-dimensional ultrasonography for a short period. The low detection rate of TGA by standard obstetric ultrasonography is attributed to technical difficulties in consistently imaging the outflow tracts.

Four-dimensional ultrasonography may overcome technical limitations related to the skills required to obtain appropriate planes. STIC allows for automatic volume acquisition of the fetal heart, storing complete volume data sets and reducing dependency on the examiner’s experience [16, 1–5]. The user can digitally store, optimize, and slice images iteratively and even transmit them to experts. Additional benefits of STIC include improved temporal resolution, an increased number of stored 2-dimensional images, and complete rotation of the heart for 3-dimensional multiplanar anatomy examination. Furthermore, the clear contrast between normal and TGA hearts obtained by 4-dimensional rendering techniques may improve parental understanding and enhance prenatal counseling.

The authors conclude that 4-dimensional STIC is a valuable tool for the prenatal diagnosis of TGA by providing a systematic approach to visualize the abnormal relationship of the outflow tracts.

This study investigates the ‘I-shaped’ sign as a novel echocardiographic marker for the antenatal diagnosis of d-transposition of the great arteries (dTGA) during routine cardiac examinations. The primary objectives were to determine the prevalence of this sign in fetuses with dTGA, those with other congenital heart diseases (CHDs), and those with normal structural hearts. This was a retrospective evaluation involving 1134 fetuses who underwent echocardiography to screen for CHD over a 4-year period.

Methods:

The researchers defined the I-shaped sign as the characteristic appearance of the aortic arch, resembling the letter ‘I’, from the most anterior to the most posterior point of the descending aorta visible in the three vessels and trachea view. A single experienced cardiologist reviewed DVD clips of the fetal echocardiograms, specifically assessing the three-vessel view and the three vessels and trachea view, from the outflow tracts to the descending aorta. The frequency of this sign was then evaluated in cases with dTGA, other CHDs, and normal hearts. The reliability of CHD diagnosis at the center was confirmed by postnatal echocardiographic examination. Statistical analysis using Pearson’s χ2 test was performed to compare the prenatal detection rates of the I-shaped sign across the different groups.

Results:

CHD was diagnosed in 671 (59.1%) of the 1134 cases, and 31 (4.6%) of these had dTGA. The I-shaped sign was observed in 30 out of 31 (96.8%) cases of dTGA. In contrast, it was seen in only 31 out of 640 (4.8%) cases with other cardiac anomalies. These other CHDs included single ventricle with pulmonary atresia or severe pulmonary stenosis, hypoplastic left heart syndrome with aortic atresia, corrected transposition of the great arteries, and double outlet right ventricle with malposition of the great arteries. Importantly, the I-shaped sign was never observed in fetuses with structurally normal hearts.

The frequency of the I-shaped sign was significantly higher in the dTGA group compared to both the normal group and the other CHDs group (both P < 0.001). The I-shaped sign demonstrated a sensitivity of 96.8% and a specificity of 97.1% for the diagnosis of dTGA. The positive predictive value for diagnosing dTGA was 49.2%, while the negative predictive value was 99.9%.

Under normal circumstances, in the three vessels and trachea view, the aortic and ductal arches are seen in a tangential cross-section, forming a V-shape pointing to the posterior thorax on the left side of the spine. However, dTGA is characterized by the I-shaped aortic arch in the same view, typically showing only one great artery. The main pulmonary artery in dTGA appears shorter than normal, and its bifurcation is visible in the three-vessel view. Computed tomography (CT) images of neonates with dTGA in the axial upper mediastinal view also showed an elongated aortic arch running across the chest in an anteroposterior direction.

Discussion:

The study highlights that the detection rate of dTGA in a non-selected population remains low because isolated dTGA often presents with a normal four-chamber view, which is the standard screening view. Prenatal diagnosis of dTGA is crucial for improving early neonatal management and reducing associated mortality and morbidity. The I-shaped sign, characterized by a long aortic arch running across the chest in an anteroposterior direction in the three vessels and trachea view, can serve as a marker to improve the sensitivity and specificity of antenatal dTGA detection, even with a normal four-chamber view.

The fact that the I-shaped sign was never observed in structurally normal hearts and its high sensitivity and specificity make it a valuable marker. While the I-shaped sign was also observed in a small percentage of other CHDs, these conditions (like single ventricle and hypoplastic left heart syndrome) are often detectable in the four-chamber view during routine screening. The I-shaped sign in these other CHDs can be attributed to the abnormal origin or course of the great vessels.

The study acknowledges that the low positive predictive value of the I-shaped sign for dTGA is due to the low prevalence of the disease. However, the high negative predictive value suggests that the absence of the I-shaped sign strongly suggests the absence of dTGA.

The authors conclude that the I-shaped sign is a sensitive, specific, and simple method for detecting dTGA during fetal echocardiography. Its detection should raise suspicion of CHD, and the combination of a normal four-chamber view with an I-shaped sign is particularly suggestive of dTGA. They believe this novel marker has the potential to improve the prenatal diagnosis of dTGA in the general low-risk population.

The study notes a limitation in its exclusive use of previously diagnosed cases, although the reviewer was blinded to the diagnosis. A prospective trial is recommended to further confirm the diagnostic effectiveness of the I-shaped sign.

This comprehensive synthesis integrates the findings and discussions from two distinct studies focusing on the prenatal diagnosis of transposition of the great arteries (TGA): a retrospective evaluation of temporal trends and outcomes over a 20-year period, and an investigation into a novel echocardiographic marker, the ‘I-shaped’ sign, for antenatal dTGA diagnosis [conversation history].

Study 1: Temporal Trends in Prenatal Diagnosis of TGA/IVS and its Impact

This retrospective study, conducted at Boston Children’s Hospital, evaluated the temporal trends in the prenatal diagnosis rate of transposition of the great arteries with intact ventricular septum (TGA/IVS) over a 20-year period (1992-2011) and its impact on neonatal morbidity and mortality. The study included 340 newborns with TGA/IVS referred for surgical management. The study period was divided into five 4-year periods, and the primary outcome was the rate of prenatal diagnosis. Secondary outcomes included neonatal pre-operative status and perioperative survival.

Key Findings:

  • Increased Prenatal Diagnosis Rate: The rate of prenatal diagnosis of TGA/IVS significantly increased over the study period, from 6% in 1992–1995 to 41% in 2008–2011 (p<0.001). Despite this improvement, the rate remained below 50%.
  • Earlier Intervention in Prenatally Diagnosed Patients: Prenatally diagnosed patients underwent balloon atrial septostomy (BAS) earlier than postnatally diagnosed patients (0 vs. 1 day, p<0.001).
  • Reduced Need for Mechanical Ventilation: Fewer prenatally diagnosed patients required mechanical ventilation (56% vs. 69%, p=0.03).
  • No Significant Difference in Mortality: There were no statistically significant differences in pre-operative acidosis or the need for pre-operative ECMO between the two groups. Similarly, no significant mortality difference was observed (1 pre-operative death in the prenatal group vs. 4 pre-operative and 6 post-operative deaths in the postnatal group). The overall mortality rate decreased but not significantly.
  • Birth Location: A significantly higher percentage of prenatally diagnosed patients (95%) were born at an obstetric unit adjacent to the cardiac center compared to postnatally diagnosed patients (5%, p<0.001).
  • Gestational Age at Birth and Admission: Postnatally diagnosed patients were born at a slightly later gestational age (38.8 vs. 38.3 weeks, p<0.001) but were admitted to the cardiac center a median of 1 day later (0 vs. 1 day, p<0.001).
  • Surgical Timing and Post-operative Outcomes: The arterial switch operation was performed at a median of 4 days in both groups, with no significant differences in post-operative ECMO or length of ICU stay. Post-operative mortality was not significantly different.
  • Mortality in Postnatally Diagnosed Remote Births: All patients in the postnatal group who died (3.8%) were born remote from the hospital.

Discussion of Study 1:

The study highlights the improvement in prenatal detection rates of TGA/IVS, likely due to increased utilization and quality of ultrasound imaging, particularly the outflow tract view (OTV). The historical reliance on the four-chamber view (4CV) alone precluded the diagnosis of TGA/IVS due to its normal appearance. The formal recommendation for incorporating the OTV by prenatal ultrasound societies in 2013 followed the trend observed in this study.

While mortality rates were not significantly different, the study emphasizes the pre-operative benefits of prenatal diagnosis, such as earlier BAS and reduced need for mechanical ventilation, potentially leading to improved hemodynamics and less hypoxemia. The lack of significant difference in pre-operative acidosis might be due to limitations in data availability from outside hospitals or the chosen pH threshold.

The authors acknowledge that the single-center, retrospective nature of the study and the exclusion of patients who died before reaching their center are limitations. The study suggests that while neonatal mortality may not show a significant difference, prenatal diagnosis might confer long-term benefits, particularly on neurodevelopmental outcomes, as suggested by other research.

Study 2: The ‘I-shaped’ Sign as a Novel Marker [conversation history]

This retrospective study investigated the ‘I-shaped’ sign in the three vessels and trachea view as a novel echocardiographic marker for the antenatal diagnosis of d-transposition of the great arteries (dTGA) [conversation history]. The study involved 1134 fetuses undergoing echocardiography [conversation history].

Key Findings:

  • High Prevalence in dTGA: The ‘I-shaped’ sign, defined as the aortic arch resembling the letter ‘I’, was observed in 96.8% of fetuses with dTGA [conversation history].
  • Low Prevalence in Other CHDs and Normal Hearts: The sign was seen in only 4.8% of cases with other congenital heart diseases (CHDs) and never in fetuses with structurally normal hearts [conversation history].
  • High Sensitivity and Specificity: The ‘I-shaped’ sign demonstrated a sensitivity of 96.8% and a specificity of 97.1% for the diagnosis of dTGA [conversation history].
  • V-shape in Normal Cases: Normally, the aortic and ductal arches form a V-shape in the three vessels and trachea view [conversation history].
  • Elongated Aortic Arch in dTGA: CT images of neonates with dTGA confirmed an elongated aortic arch running across the chest in an anteroposterior direction, corresponding to the ‘I-shaped’ sign [conversation history].

Discussion of Study 2:

This study suggests that the ‘I-shaped’ sign is a sensitive and specific marker for antenatal detection of dTGA, potentially improving diagnostic rates even when the four-chamber view appears normal [conversation history]. The normal four-chamber view in isolated dTGA contributes to low detection rates with standard screening [conversation history].

The ‘I-shaped’ sign’s absence in normal hearts and high sensitivity make it a valuable tool [conversation history]. While observed in a small percentage of other CHDs, those conditions are often detectable via the four-chamber view [conversation history]. The low positive predictive value is attributed to the low prevalence of dTGA, but the high negative predictive value indicates that the absence of the sign strongly suggests the absence of dTGA [conversation history].

The authors conclude that the ‘I-shaped’ sign is a simple and effective method for detecting dTGA during fetal echocardiography and its detection should prompt further investigation, especially when combined with a normal four-chamber view [conversation history].

Integration and Conclusion:

Both studies underscore the importance of improving prenatal diagnosis of TGA. The first study demonstrates a temporal improvement in detection rates, likely influenced by the increasing use of the outflow tract view. However, it also highlights that detection rates remain suboptimal. The second study introduces a novel marker, the ‘I-shaped’ sign in the three vessels and trachea view, which exhibits high sensitivity and specificity for dTGA [conversation history].

Integrating these findings suggests that incorporating the three vessels and trachea view, specifically looking for the ‘I-shaped’ sign, into routine prenatal ultrasound screening protocols could significantly enhance the detection rate of TGA, even in cases with a normal four-chamber view [8, conversation history]. Improved prenatal diagnosis, as shown in the first study, can lead to earlier interventions like BAS and reduced pre-operative morbidity, potentially contributing to better long-term neurodevelopmental outcomes, although mortality benefits may be less apparent in contemporary settings due to advancements in postnatal care. Further prospective studies are warranted to validate the clinical utility of the ‘I-shaped’ sign in broader populations [conversation history]. The ongoing efforts to educate sonographers and physicians on the performance and interpretation of views beyond the four-chamber view, as emphasized in the first study, are crucial for achieving higher prenatal detection rates of critical CHDs like TGA.

This updated review focuses on the ultrasound markers that can be used in the antenatal diagnosis of transposition of the great arteries (TGA), emphasizing the tools utilized by ultrasonographers, the obstetric and fetal medicine team, and perinatal cardiologists to improve the diagnosis of this condition.

Introduction and Significance of Prenatal Diagnosis:

Simple TGA is a cyanotic heart disease that accounts for 5% to 7% of all congenital heart diseases (CHDs). It is commonly underdiagnosed in utero, with prenatal detection rates of less than 50%. Simple TGA is characterized by ventriculoarterial (VA) discordance, atrioventricular (AV) concordance, and a parallel relationship of the great arteries. The prenatal diagnosis of TGA influences postnatal outcomes and therefore necessitates planned delivery and perinatal management. Consequently, the identification of key ultrasound markers of TGA is crucial to enhance prenatal diagnosis and subsequently provide appropriate perinatal assistance. The diagnosis of several CHDs has improved through the evaluation of outflow tracts in the four-chamber view during cardiac screening and the use of advanced ultrasound technologies like 3D and 4D ultrasonography/echocardiography. However, simple TGA remains one of the most commonly underdiagnosed CHDs in utero.

Terminology and Morphology of TGA:

In TGA, the aortic artery arises from the anterior ventricle (morphological right ventricle – RV), while the pulmonary artery originates from the posterior ventricle (morphological left ventricle – LV). Earlier definitions of TGA sometimes included other cardiac malformations, leading to the use of the term “complete TGA” to avoid ambiguity. Complete transposition is defined by AV concordance and VA discordance and can occur with a normal (solitus) or mirror-imaged (inversus) arrangement of the atria, excluding hearts with atrial isomerism. It is important to differentiate TGA from congenitally corrected transposition of TGA, which involves ventricular inversion along with a transposed relationship of the great arteries (discordant VA and AV connections).

The primary morphological characteristics of TGA include:

  • AV concordance with VA discordance.
  • The interventricular septum does not exhibit the normal curvature of a normal heart.
  • The great arteries have a parallel arrangement, with the aortic valve positioned anteriorly and to the right of the pulmonary valve (dextro-TGA [d-TGA]).

Types of TGA include d-TGA, levo-TGA, simple TGA (without associated cardiac anomalies), and complex TGA (with other cardiac malformations). Simple TGA is more prevalent than the complex form. Common associated cardiac anomalies are ventricular septal defects (VSDs), often with malalignment of the outlet septum, and LV or RV outflow tract obstructions. Sub-pulmonary stenosis is suspected if the outlet septum deviates posteriorly and leftward, while sub-aortic stenosis may occur with anterior and rightward deviation and fibrous continuity between the pulmonary and mitral valves. LV outflow tract obstruction is more common in TGA patients with VSD. Other congenital cardiac anomalies associated with TGA include coronary anomalies, right aortic arch, and anomalous venous connections, more frequent in TGA patients with VSDs. Chromosomal and extracardiac anomalies are rare in patients with TGA. TGA is more frequent in fetuses of pregnant women with pre-gestational diabetes mellitus, a history of exposure to pesticides, or retinoic acid use in the first trimester.

Prenatal Diagnosis of TGA by Ultrasonography and Echocardiography:

Guidelines for fetal cardiac screening and training programs can maximize CHD detection rates, especially in low-risk fetuses. Since 2013, the International Society of Ultrasound in Obstetrics and Gynecology and the American Institute of Ultrasound in Medicine have included the evaluation of outflow tracts in the four-chamber view for cardiac ultrasound screening. This has improved the sensitivity of ultrasound screening for CHD from approximately 30% to 69%-83%. The three-vessel view and three-vessel tracheal view were also incorporated into the cardiac ultrasound screening protocol, involving the assessment of the aorta, pulmonary artery, and superior vena cava. Despite these advancements, the antenatal diagnosis rate of TGA has not significantly improved.

The key markers for diagnosing TGA include:

  • The presence of two vessels instead of three in the three-vessel tracheal view. This is sometimes referred to as the “misnomer three vessels“. In TGA, only the aorta and superior vena cava are typically seen due to the anterior position of the aorta relative to the pulmonary artery. However, this sign is not pathognomonic for TGA and can be observed in other conotruncal anomalies.
  • A parallel course of the great arteries. Outflow tract views demonstrate the parallelism of the aorta (anterior) and the pulmonary artery (posterior).
  • Identification of the origin of each great artery.

In addition to these classical signs, other two-dimensional ultrasound markers include:

  • An abnormal right convexity of the aorta arising from the RV instead of the normal leftward convexity when the pulmonary artery arises from the RV.
  • An I-shaped aorta in the upper mediastinum, representing the long aorta arising from the RV. This “I-sign” was observed in a high percentage of TGA cases.
  • The “boomerang sign,” describing the rightward convex curvature of the RV outflow tract (aorta). This sign highlights the reverse curvature of the RVOT in TGA and can be an earlier marker.

Advanced ultrasound technologies can also aid in diagnosis:

  • Four-dimensional (4D) technologies such as spatio-temporal image correlation (STIC) and sonographically-based volume computer-aided analysis (sono-AVC) may improve the prenatal diagnosis of TGA. Sono-AVC has been shown to enable automatic retrieval of abnormal ventricular outflow tracts in fetuses with TGA.
  • The “baby bird’s beak image,” representing the bifurcation of the pulmonary artery arising from the LVOT, can be a key indicator. However, visualizing this bifurcation can be challenging.
  • The “big-eyed frog” sign observed using STIC, where the side-by-side great vessels resemble the character “Keroppi,” has also been described as useful.

Studies have shown that detailed analysis of the outflow tract views is crucial for prenatal detection. The increase in antenatal diagnosis rates of TGA in some studies has been attributed to improvements in outflow tract screening aided by the four-chamber view on routine obstetric ultrasound.

Conclusion:

TGA is a critical CHD that remains underdiagnosed prenatally. Antenatal diagnosis, especially of simple d-TGA, is essential for reducing morbidity and mortality. Reliable clues for diagnosis through obstetric cardiac screening and fetal echocardiography are therefore vital. While the “misnomer three vessels” provides a strong suspicion, it is not pathognomonic. An I-shaped appearance of the arterial vessel increases suspicion. Detailed analyses of the outflow tracts serve as a clue to improve in utero diagnosis. Traditionally, diagnosis relied on identifying the pulmonary artery bifurcation from the LVOT, which is difficult. However, the LVOT should be assessed if a long vessel with a rightward reverse curvature (aorta) arises. The “boomerang sign” appears to be an easier and earlier marker.

This original research article, published on March 6, 2024, in Frontiers in Cardiovascular Medicine, presents a retrospective analysis of 121 prenatally diagnosed patients with transposition of the great arteries (TGA) at a single Chinese hospital (Fujian Maternity and Child Health Hospital) between January 2012 and September 2022. The study aimed to assess the diagnostic value of prenatal echocardiography for identifying TGA during pregnancy and evaluating the associated outcomes. The analysis included prenatal ultrasound, prenatal screening, clinical management, and follow-up procedures.

Objective and Methods: The primary objective was to evaluate the diagnostic capabilities of prenatal echocardiography for TGA and its impact on pregnancy outcomes. The study retrospectively analyzed data from 103 fetuses that met the inclusion criteria out of the initial 121 pregnant women diagnosed with TGA. The inclusion criteria involved undergoing routine prenatal screening with complete measurements, having pathological examinations (if pregnancy was terminated), and undergoing fetal echocardiography and neonatal congenital heart disease screening at their hospital. Pregnant women and their families provided consent for the study, which was approved by the hospital’s Ethics Committee. Prenatal assessments were conducted using GE Voluson E8 and E10 ultrasonic diagnostic devices with convex array probes (2.0–9.0 MHz) for transabdominal examinations and intracavitary probes (5.0–8.0 MHz) for suspected TGA in early pregnancy. Neonatal examinations utilized a Phillips IPEIQ 7C device with a phased array probe (3.0–8.0 MHz). Data on perinatal management and follow-up outcomes were collected from medical records. Fetal heart exams, including four-section, nine-section, and two-section examinations across trimesters, were performed with sequential segmental analysis focusing on the connections of the atria, ventricles, and great arteries. Key aspects assessed during ultrasound included atrioventricular and ventriculoarterial connections, great artery characteristics and crossing relationship, and the presence of ventricular septal defect (VSD) and outflow tract stenosis. The size and blood flow of the foramen ovale and ductus arteriosus were evaluated in fetuses without VSD, and extracardiac malformations were also noted. Prenatal diagnosis was strongly recommended, including noninvasive prenatal genetic testing (NIPT) for chromosomal aneuploidy and mid-trimester serological screening. Amniocentesis and umbilical vein puncture were performed for further evaluation with G-banded karyotype analysis and single nucleotide polymorphism microarray (SNP array) analysis. A multidisciplinary approach involving obstetrics, ultrasound, and paediatrics departments facilitated personalized pregnancy plans and neonatal care, with referral to paediatric cardiac surgeons when needed. Live-born infants underwent postnatal echocardiography, with follow-up via telephone communication. Statistical analysis was performed using SPSS Statistics 26 software, with a significance level of P < 0.05.

Results: Out of the 103 fetuses, 90 (87.4%) were diagnosed with complete transposition of the great arteries (D-TGA), and 13 (12.6%) exhibited corrected transposition of the great arteries (CC-TGA). Diagnoses occurred across all trimesters: 8 D-TGA and 2 CC-TGA in the first trimester, 68 D-TGA and 9 CC-TGA in the second trimester, and 14 D-TGA and 2 CC-TGA referred in the third trimester. Characteristic echocardiographic features of D-TGA in early pregnancy included rightward-bent great vessels in the three-vessel-tracheal view, juxtaposed great vessels in the outflow tract oblique view, and consistent atrioventricular connections in the four-chamber view. In the second trimester, D-TGA showed the aorta connected to the right ventricle and the pulmonary artery to the left ventricle, with parallel great arteries (aorta anterior to the pulmonary artery). CC-TGA presented with discordant atrioventricular connections in early pregnancy. In the second trimester, CC-TGA displayed reversed ventricular positions, parallel outflow tracts, pulmonary arteries from the left ventricle, and the aorta from the right ventricle positioned anterior to the pulmonary artery. The earliest diagnosis was at 12 weeks and 3 days of gestation. Combined intracardiac malformations were observed in 80 (77.7%) TGA patients, while 31 (30.0%) had extracardiac abnormalities. Among D-TGA patients, common intracardiac malformations were ventricular septal defects (VSDs) in 56 (62.2%), pulmonary artery stenosis in 19 (21.1%), and tricuspid valve abnormalities in 9 (10.0%). Common extracardiac abnormalities in D-TGA included fetal growth restriction (12.2%), NT/NF thickening (5.5%), and single umbilical artery (3.3%). In CC-TGA, VSD was the most prevalent intracardiac abnormality in 8 (61.5%) patients. Prenatal screening for Down syndrome was performed in 46 fetuses, with 7 high-risk cases (6 D-TGA, 1 CC-TGA). NIPT was low risk in all 16 cases where it was performed. Prenatal diagnosis was conducted in 40 fetuses, revealing chromosomal abnormalities in 3 cases: standard trisomy 18, partial trisomy 5, and 21pstk + polymorphism, leading to pregnancy termination in all three cases. Induction of labour was pursued for 76 D-TGA patients (84.4%) and 11 CC-TGA patients (84.6%), while 14 D-TGA patients (15.6%) and 2 CC-TGA patients (15.4%) continued pregnancy until delivery. Among the D-TGA patients who continued pregnancy, 9 (10.0%) underwent surgery, with 7 positive outcomes and 2 inadvertent fatalities. Seven D-TGA patients received palliative care, leading to 4 fatalities (5.2%), while 1 survived. Among CC-TGA patients who continued pregnancy, surgery was not recommended, and telephone follow-up indicated a good prognosis for the survivors.

Discussion: The study highlights the feasibility of accurate prenatal TGA diagnosis, even in early pregnancy, emphasizing the role of comprehensive ultrasound scanning techniques. The detection rate of TGA has increased significantly in recent years due to improved screening protocols. Prenatal diagnosis is crucial for informed parental decisions and timely postnatal intervention, potentially reducing severe complications and mortality. While TGA is typically not strongly linked to chromosomal abnormalities or extracardiac malformations, this study found a higher rate of chromosomal abnormalities in D-TGA fetuses (7.5%) compared to the general population. The study acknowledges that some TGA cases were missed during early pregnancy, possibly due to the near-normal appearance of the four-chamber view and misinterpretation of outflow tract views. The short axis view of the great arteries and basal outflow tract view are important for accurate diagnosis and for assessing associated VSDs. The high rate of induced labour in this study (74.8% of pregnancies diagnosed in the second trimester were terminated) might be attributed to China’s previous fertility policy, where families often chose termination if fetal heart abnormalities were detected. However, with the implementation of the three-child policy, this trend is expected to decrease as societal views on fetuses with congenital heart disease evolve and treatment options improve. The study underscores the importance of detailed prenatal ultrasound assessment, including the interventricular septum, valve morphology, and the presence of stenosis in the pulmonary arteries. Postoperative ultrasound monitoring should focus on aortic and pulmonary artery conditions, VSD, aortic coarctation, and potential arrhythmias. The direction of prenatal diagnosis should align with integrated management, involving multidisciplinary consultation and individualized treatment plans.

Limitations and Conclusion: The study acknowledges limitations such as the small sample size from a single center, its retrospective design, a limited number of genetic examinations, and a relatively short follow-up duration. The study did not report on fetal brain and nervous system lesions, which would be clinically significant. Further research is needed to investigate the long-term mobility, mortality, and quality of life of TGA patients. The conclusion of the study reiterates that precise TGA diagnosis is achievable in early pregnancy through echocardiography. For pregnancies that continue, comprehensive prenatal ultrasound monitoring, personalized perinatal management, and multidisciplinary intervention during delivery are vital for optimizing outcomes in the TGA population.

This original paper, published in Ultrasound in Obstetrics and Gynecology in 2013, presents a study investigating a novel fetal marker for transposition of the great arteries (TGA): the rightward convexity of the great vessel arising from the anterior ventricle. The authors aimed to determine if this finding could aid in the prenatal diagnosis of TGA, as traditional methods relying on the bifurcation of the great vessel from the posterior ventricle and the parallel course of the great arteries can be difficult to demonstrate, sometimes requiring additional echocardiographic features.

Background and Objectives: The authors begin by highlighting that the diagnosis of conotruncal abnormalities, including TGA, remains challenging despite advancements in technology and training, with antenatal detection rates for simple TGA being notably low compared to other congenital heart diseases. Traditionally, the fetal diagnosis of TGA has depended on observing the bifurcation of the great vessel originating from the posterior (left) ventricle and the parallel path of the great arteries leaving the heart, indicating a lack of crossover. However, these signs can be challenging to visualize, particularly in simple TGA cases where the four-chamber view might appear normal. The study also mentions the importance of the three vessels and trachea (3VT) view, also known as the transverse arches view, in diagnosing conotruncal abnormalities, including TGA. Emphasizing the importance of prenatal TGA detection for anticipatory management of the newborn, the researchers undertook a review of their experience to explore the prevalence of the rightward convexity of the great vessel from the anterior ventricle in confirmed TGA cases as a potentially easier diagnostic finding.

Methods: The researchers retrospectively reviewed fetal ultrasound studies conducted between 2006 and 2010 where an antenatal diagnosis of TGA was confirmed postnatally. They specifically analyzed images of the great vessel originating from the anterior ventricle, scanned cranially towards the superior mediastinum at the level of the three vessels and trachea view. These images were then compared with similar views obtained from normal fetal hearts with normally related great arteries. The study included 21 confirmed cases of TGA. The researchers meticulously followed the course of the great vessel from the anterior ventricle up to the 3VT view in all these cases.

Results: The study found that in all 21 confirmed cases of TGA, the great vessel arising from the anterior ventricle (which is the aorta in TGA) demonstrated an abnormal convexity to the right as it coursed cranially. This was consistently different from normal hearts, where the great vessel arising from the anterior ventricle (the pulmonary artery) showed either a convexity to the left or a lack of convexity in similar views. Notably, in two cases, the rightward vessel convexity from the anterior ventricle served as the initial clue that suggested TGA during the initial scan, which was subsequently confirmed. Furthermore, the study observed that in fetuses with TGA, the so-called 3VT view often appeared as a two-vessel view, showing only the superior vena cava and the aorta, because the pulmonary artery and ductus arteriosus were positioned below (caudal to) the transverse arch. In contrast, normal fetal hearts in the 3VT view show three vessels: the superior vena cava, the pulmonary artery, and the transverse aortic arch, with the pulmonary artery exhibiting a leftward convexity. The authors were unable to definitively determine if any TGA cases were missed during the study period due to limitations in follow-up data from fetuses delivered at other hospitals. However, they considered it likely they would have been informed of any missed TGA diagnoses given the centralized pediatric cardiac care in Melbourne.

Discussion and Conclusions: The authors discussed the feasibility and importance of the 3VT view as a routine part of fetal cardiac screening, aligning with guidelines from the International Society of Ultrasound in Obstetrics and Gynecology that recommend visualizing the ventricular outflow tracts. They noted that sequential segmental imaging of the fetal heart could aid in diagnosing TGA, especially when traditional signs are unclear. The study highlights the contrast between the normal fetus, where the pulmonary artery exhibits leftward convexity or a straight course in the superior mediastinum, and the fetus with TGA, where the aorta from the anterior ventricle shows a distinct rightward convexity. The finding of a two-vessel 3VT view in TGA, due to the altered spatial relationship between the aorta and pulmonary artery, is also emphasized as a potential screening tool, although not definitively diagnostic. The authors propose that the rightward convexity of the great vessel from the anterior ventricle is a relatively simple sonographic sign that could aid even less experienced sonographers in the prenatal diagnosis of TGA. While the two-vessel 3VT view can also be suggestive, the rightward convexity was the initial clue in two of their prospectively identified cases. The authors caution that other cardiac anomalies, such as double outlet right ventricle or tetralogy of Fallot (especially with pulmonary atresia), might also present with an aorta taking a convex course from the right ventricle, meaning this sign is not entirely pathognomonic for TGA. Nevertheless, they suggest that this finding should prompt further investigation and referral to a specialist center. The authors conclude by suggesting that these easily obtainable sonographic signs could enhance routine screening for TGA and might become preferred views for antenatal detection. They recommend a prospective study to further evaluate if following the course of the great vessel from the anterior ventricle can improve TGA detection rates, particularly in uncertain cases where traditional views are not easily obtained.

This case report, available online through ScienceDirect on the journal homepage of Elsevier, presents the experience of the authors in the sonographic diagnosis of D-Transposition of Great Arteries (d-TGA) during the mid-trimester of pregnancy. The authors, from various military hospitals in India, report four cases of d-TGA that were diagnosed antenatally by demonstrating parallel outflow tracts. The paper emphasizes that although d-TGA is a common critical cardiac lesion in newborns, it is frequently missed on antenatal sonography, with recent studies indicating only 23% detection of isolated cardiac anomalies antenatally. The authors aim to highlight their experience using a systematic approach to differentiate d-TGA from L-Transposition of Great Arteries (l-TGA).

Case Reports:

The paper details four case reports where d-TGA was diagnosed during routine anomaly scans:

  • Case 1: A 22-year-old primigravida at 24 weeks of gestation was referred for an anomaly scan, which revealed an isolated fetal cardiac anomaly. The visceral-atrial situs and four-chamber view were normal. However, the outflow tract evaluation showed the main pulmonary artery (MPA) originating from the left ventricle (LV) and the aorta originating from the right ventricle (RV). A ventricular septal defect (VSD) and a parallel relationship of the outflow tracts were also observed. Color Doppler confirmed the parallel outflow tracts with VSD. The patient was referred to a tertiary care hospital in the third trimester, and postnatal echocardiography confirmed the findings. The neonate underwent surgery, and no other associated anomalies were found.
  • Case 2: A 24-year-old primigravida was referred for an anomaly scan at 20 weeks of gestation due to a suspected outflow tract anomaly. The scan revealed that the aorta originated from the RV, and the MPA originated from the LV with a component of overriding. Color Doppler confirmed the parallel outflow tracts. The patient was referred to a tertiary care hospital in the third trimester, and postnatal echocardiography confirmed the findings. No other anomalies were found. Unfortunately, the neonate died of complications secondary to the cardiac anomaly before the scheduled surgery.
  • Case 3: A 20-year-old primigravida underwent an anomaly scan at 18 weeks of gestation, revealing an isolated fetal cardiac anomaly. The MPA was seen originating from the LV, and the aorta from the RV. Both outflow tracts displayed a parallel relationship at their origin. The patient was referred to a tertiary care hospital, but the baby was born prematurely at 32 weeks in a zonal hospital. After initial management, the neonate was transferred to a tertiary care hospital and operated upon for d-TGA. Sadly, the infant died of complications at 6 months of age at the zonal hospital.
  • Case 4: A 23-year-old G2P1 patient reported for an anomaly scan at 18 weeks of gestation. The scan revealed an isolated fetal cardiac anomaly with parallel outflow tracts and ventriculoarterial discordance. Figure 4 in the source likely depicts this case.

Discussion:

The authors note that d-TGA is the second most common cyanotic congenital heart disease diagnosed in the first year of life, with a reported incidence of 315 per million live births. It is more prevalent in males, with a male to female ratio of 2:1 to 3:1. Embryologically, d-TGA is hypothesized to result from a failure of conoventricular rotation and the persistence of the subaortic conus with complete resorption of the subpulmonic conus, leading to this conotruncal anomaly.

The authors highlight that unlike other conotruncal anomalies, d-TGA is rarely associated with chromosomal anomalies or extracardiac malformations, which was consistent with their cases. While maternal diabetes has been linked to an almost three-fold increased risk of TGA, none of the patients in this series were diabetic. Animal studies have also suggested a link between maternal use of phenobarbitone and cardiovascular anomalies, including TGA.

The antenatal diagnosis of d-TGA essentially relies on demonstrating parallel outflow tracts or the absence of criss-crossing of the great arteries. The authors propose that the reliable differentiation from physiologically corrected TGA (l-TGA) can be achieved by incorporating the following steps into routine fetal heart evaluation:

  • (A) Demonstration of normal visceral-atrial situs and axis: Key indicators include the foramen ovale flap opening into the left atrium, the interatrial septum bulging from right to left, and the right atrium appearing larger.
  • (B) Demonstration of atrioventricular concordance: This crucial step involves differentiating the right ventricle (RV) from the left ventricle (LV) based on reproducible differences such as:
    • The presence of an echogenic moderator band in the RV.
    • The tricuspid valve insertion into the septum being offset towards the apex.
    • The lumen of the LV being longer and triangular in shape compared to the RV.
    • The irregularity of the endocardial surface of the RV compared to the LV. Figure 1 likely illustrates some of these differences.
  • (C) Demonstration of the branching pattern of great vessels: The authors found that the branching pattern of the MPA is more easily demonstrated in TGA cases. They also note that the ductus arteriosus often originates at an acute angle from the left pulmonary artery in TGA, and its intactness can be visualized in the outflow view.

The authors emphasize that antenatal diagnosis is crucial as it allows for planned delivery at a tertiary care hospital, which reduces mortality among survivors.

Conclusion:

The authors conclude that d-TGA remains a significant cause of critical heart anomaly in newborns associated with substantial mortality and morbidity. However, by implementing a step-wise scientific approach, this conotruncal anomaly, which is uncommonly detected antenatally, can be more easily diagnosed during anomaly scans. They suggest that the inclusion of these systematic and reproducible steps can improve antenatal detection rates.

This original paper, published in Ultrasound in Obstetrics and Gynecology in 2008, presents a prospective observational study aimed at assessing the utility of four-dimensional (4D) echocardiography with color Doppler imaging in determining the spatial relationships of the great arterial trunks in fetuses diagnosed with Transposition of the Great Arteries (TGA). The main objective of the study was to evaluate whether the reconstructed en-face view of the four cardiac valves could demonstrate different types of spatial arrangements of the great arteries, thereby helping to predict the risk of coronary arterial abnormalities. A secondary objective was to evaluate the type of coronary arterial branching pattern in relation to the spatial arrangement of the great arteries. The authors emphasize that coronary arterial abnormalities are a significant negative prognostic indicator in TGA.

Methods:

The study included 23 consecutive fetuses with a confirmed diagnosis of isolated TGA (no major associated cardiac defect) referred to two institutions (University Federico II of Naples and Di Venere Hospital, Bari) between January 2004 and December 2006. The gestational age at the time of 4D echocardiography ranged from 19 to 33 weeks. During the same period, a total of 496 fetuses with congenital heart disease (CHD) were seen at these centers.

All fetuses underwent 2D and 4D echocardiography using a Voluson 730 Expert ultrasound machine. Color Doppler volume datasets were acquired in each case, with a total of 28 volumes available for assessment. Specific criteria were followed during volume acquisition: 1) the apical four-chamber view was used as a reference plane, and 2) a high persistence setting was used for color Doppler to simultaneously display atrioventricular and ventriculoarterial flow. The acquisition angle ranged from 25° to 30°, and the acquisition time from 10 to 15 seconds.

The 4D volume datasets were processed offline using dedicated software (4D-viewer 5.0, General Electric). Post-processing involved standardization of the image appearance and the activation of the rendering function. The region of interest (ROI) box was placed across the atrioventricular plane, with the green reference line initially on the atrial side; if the arterial orifices were not clearly separated, the green line was moved to the ventricular side. The transparent mode was used for the grayscale component, and the surface mode for the color Doppler component. The cineloop sequence of the rendered glass-body image was reviewed frame by frame to identify the best frame showing the relationship between the atrioventricular and ventriculoarterial valves, identified by color flow mapping.

The classification system used to define the spatial relationships of the great arteries was based on a postmortem study by Massoudy et al., which includes five variants in decreasing order of frequency:

  • Aorta anterior to and to the right of the pulmonary trunk.
  • Aorta directly anterior to the pulmonary artery.
  • Side by side, with the aorta on the right and the pulmonary trunk on the left (Figure 1 and 2d).
  • Aorta anterior to and to the left of the pulmonary artery.
  • Aorta posterior to and to the right of the pulmonary artery (Figure 2).

Confirmation of the vessels’ arrangement and coronary arterial distribution was obtained at neonatal echocardiography and/or surgery in all cases. The spatial relationships and coronary arterial distribution were gathered from catheterization and/or surgical files.

Results:

The spatial relationships of the great arteries could be demonstrated in all 10 normal fetuses in the preliminary series and were correctly identified in 20 out of 23 (87%) cases with TGA.

Neonatally, the following spatial relationships of the great arteries were found in the 23 TGA cases:

  • Aorta anterior to and to the right of the pulmonary trunk: 13/23 cases (56.5%).
  • Aorta directly anterior to the pulmonary artery: 6/23 cases (26.1%).
  • Side by side (aorta on the right, pulmonary trunk on the left): 4/23 cases (17.4%) (Figure 2d).

The two rarer variants (aorta anterior and to the left of the pulmonary artery; aorta posterior and to the right of the pulmonary artery) were not observed in this fetal series.

In the three misdiagnosed cases, prenatal assessment suggested the aorta was anterior and to the right of the pulmonary artery, while it was actually directly anterior. Notably, all three of these cases had an associated ventricular septal defect (VSD), and two also had aortic coarctation (AoCo).

Five of the 23 TGA fetuses (21.7%) had abnormal coronary arterial distribution. The distribution of these abnormalities based on the spatial relationship of the great arteries was as follows:

  • One case with the aorta anterior to and to the right of the pulmonary artery had abnormal coronary arterial distribution.
  • Three cases with the aorta anterior to the pulmonary artery had abnormal coronary arterial distribution.
  • One case with the vessels side by side had abnormal coronary arterial distribution.

Table 1 provides a detailed breakdown of the spatial arrangement of the great arteries, coronary arterial distribution, gestational age, and additional anomalies in each of the 23 cases.

Discussion:

The authors highlight that abnormalities of the coronary arteries can complicate the surgical approach to TGA. These abnormalities, such as intramural origin, tangential course, and dual or single sinus origin, are generally too subtle to be directly visualized on fetal echocardiography. Therefore, prenatal counseling for TGA fetuses has historically lacked this crucial prognostic information.

However, the study demonstrates that 4D echocardiography, specifically the en-face view of the four cardiac valves, allows for the definition of the spatial relationships of the great arteries in fetuses with TGA with a high degree of accuracy (87%). This information is significant because the incidence of abnormal coronary arterial distribution is related to the spatial relationships of the arterial trunks.

The study’s findings on the relative incidence of the different spatial arrangements of the great arteries were reasonably similar to those reported in postmortem and neonatal echocardiographic studies, despite the smaller sample size of this fetal series (Table 2). The most common arrangement, aorta anterior and to the right of the pulmonary artery, was consistent across all three series.

The authors address two key technical aspects: the identification of the four cardiac valves and the use of color Doppler. They emphasize that valve identification should be done on multiplanar imaging before switching to the en-face view, using the ROI window markers. Regarding color Doppler, while a high persistence setting was used to visualize both atrioventricular and ventriculoarterial flow simultaneously in a single frame, the spatial relationships can also be assessed by evaluating the whole cineloop sequence even with lower persistence, provided the four-chamber view was appropriately oriented during volume acquisition.

The analysis of the incidence of coronary arterial branching abnormalities based on the spatial arrangement showed some differences compared to the postmortem and neonatal series, potentially due to the different sample populations and the small size of the fetal cohort. The rarer spatial arrangements associated with the highest risk of coronary anomalies in other studies were not encountered in this series, likely due to the limited number of cases.

Conclusion:

The study concludes that 4D echocardiography can reliably assess the spatial relationships of the great arteries in fetuses with TGA. This capability allows for the derivation of the risk of coronary arterial distribution abnormalities, providing valuable information for prenatal counseling. It enables healthcare professionals to reassure couples whose fetus has a TGA with an anatomy associated with a low risk of coronary anomalies and to highlight potential increased surgical risks in cases with spatial arrangements where abnormal coronary patterns are more likely. The authors suggest that this advancement can contribute to more informed and customized prenatal counseling for fetuses diagnosed with TGA.

Fetal thoracic ultrasound pathologies

Overview

This body of work gathers a collection of scientific articles addressing various fetal malformations of the thorax and upper abdomen diagnosed through prenatal ultrasound, along with their management and prognosis. The main topics explored include congenital chylothorax, congenital diaphragmatic hernia (CDH), congenital pulmonary malformations (CPM), Pallister-Killian syndrome (PKS) when it presents with thoracic involvement, and fetal mediastinal teratoma.

Regarding congenital chylothorax, these articles delve into diagnostic aspects, such as the biological characteristics of pleural fluid, and the diverse strategies for prenatal management, spanning from observation to pleural aspiration and pleuro-amniotic shunting. The prognosis is evaluated considering factors like the extent of the fluid collection and the presence of anasarca.

A significant portion of this literature focuses on congenital diaphragmatic hernia (CDH). Numerous articles emphasize the importance of antenatal ultrasound diagnosis, including the identification of associated anomalies and prognostic assessment using measurements such as the Lung-to-head ratio (LHR) and the observed-to-expected LHR (O/E-LHR). Management protocols in specialized centers, comprehensive fetal evaluation to exclude concurrent abnormalities, and therapeutic options, including fetal interventions like tracheal occlusion (FETO) and sildenafil administration, are also extensively discussed. One study specifically investigates the role of fetal stomach position as a predictor of gastrointestinal morbidity at 2 years in children with left-sided CDH. The association of CDH with genetic conditions, notably Pallister-Killian syndrome (PKS), is also highlighted, underscoring the need for specific testing for trisomy 12p in certain cases.

 

Congenital pulmonary malformations (CPM) constitute another key area of investigation. These articles examine prenatal detection via ultrasound, the classification of lesions (cystic, hyperechoic, mixed), and the natural progression of the volume of these malformations during gestation, particularly using the Congenital Pulmonary Malformation Volume Ratio (CVR). The primary aim is to identify predictors of neonatal respiratory distress and related complications, thereby optimizing perinatal care and guiding delivery to specialized facilities. The consistency between prenatal ultrasound findings and postnatal diagnoses is also a subject of analysis.

Pallister-Killian syndrome (PKS) is specifically examined through a retrospective multicenter study comparing prenatal (ultrasound) and fetopathological data. This work aims to define prenatal indicators suggestive of PKS beyond the classic diaphragmatic hernia, highlighting the broad spectrum of malformations associated with this rare condition.

Finally, a case study of fetal mediastinal teratoma is presented, illustrating the potential for misdiagnosis with cystic lung lesions on prenatal ultrasound and emphasizing the associated fetoplacental complications.

Overall, this body of work provides insights into the challenges and advancements in the prenatal diagnosis of fetal malformations affecting the thorax and upper abdomen. It underscores the critical role of ultrasound as a central tool for screening, diagnosis, and prognostic evaluation, while acknowledging the complexity of these conditions and the necessity of a multidisciplinary approach to optimize management and improve outcomes for affected fetuses and newborns. The detailed examination of these various aspects contributes to a deeper understanding of the clinical issues and future research directions in this field.

Bibliographie

The article “Prise en charge prénatale des chylothorax” by R. Favre discusses the prenatal management of congenital chylothorax, also initially referred to as primary hydrothorax.

Definition and Incidence:

  • The article states that hydrothorax can be primary or secondary.
  • Primary hydrothorax will meet the postnatal criteria for chylothorax.
  • These criteria include triglyceride levels of 1.1 mmol/l and a lymphocyte count greater than 80% [2, citing]. However, the 80% lymphocyte threshold is noted as controversial [2, citing].
  • The incidence of hydrothorax is reported to be in the order of 1/10,000 to 1/15,000 pregnancies.

Etiology and Pathophysiology:

  • Primary hydrothorax is a consequence of lymphatic leakage into the pleural space and can be unilateral or bilateral.
  • The most probable etiology is an anomaly of the thoracic lymphatic duct or pulmonary lymphangiectasia [2, citing].
  • Secondary hydrothorax is linked to pulmonary pathologies or general diseases, and its prognosis depends closely on the underlying cause.

Diagnostic Approach:

  • The diagnostic process for primary hydrothorax involves excluding associated malformations, fetal infection, chromosomal abnormality, and fetal anemia [2, citing].
  • Positive diagnostic criteria mentioned include thoracic compression (evaluated during pleural puncture), superior vena cava edema, a very high rate of lymphocytes in the puncture fluid, and good pulmonary expansion at the end of pleural drainage.
  • The presence of hydramnios and especially anasarca are aggravating factors [3, citing].
  • The diagnostic approach should aim to differentiate between primary and secondary effusions to better define management.

Natural History and Prognosis:

  • The natural history shows that spontaneous regression of hydrothorax is possible in 22% of cases [3, citing].
  • However, this evolution is less likely in cases of massive effusion and anasarca.
  • Hydrothorax can lead to pulmonary hypoplasia, mainly during the period of 16-24 weeks [3, citing].
  • The progression of hydrothorax and especially the appearance of anasarca are the most important predictive factors [3, citing].
  • The use of the effusion ratio might help in better selecting fetuses who could benefit from aggressive therapy [3, citing].
  • Maternal complications can occur with fetal hydrothorax, mainly pre-eclampsia and mirror syndrome. The maternal situation may improve with fetal treatment [3, citing].
  • The prognosis of primary hydrothorax depends on the severity and the development of anasarca [2, citing].
  • The survival rate for those with persistent effusion is better in the absence of anasarca, averaging 80% versus 50%.

Prenatal Management:

The article discusses several approaches to prenatal management:

  • Conservative Approach (1.1):
    • Spontaneous resolution of primary hydrothorax can occur, making a conservative approach reasonable for moderate effusions without hydrops.
    • Reported survival rates with this approach are 73 to 100% [4, citing].
    • In a series of 204 cases, 89 did not receive in utero treatment, and the observed mortality rate was 39% [4, citing].
  • Pleural Puncture (Thoracocentesis) (1.2):
    • Pleural puncture can be diagnostic but also therapeutic, particularly in the prepartum period.
    • The rationale is thoracic decompression and the continuation of pulmonary growth.
    • In most cases, the fluid re-accumulates rapidly.
    • Theoretically, repeated punctures could induce hypoproteinemia, increasing the risk of anasarca [4, citing].
    • The published survival rate after thoracocentesis is 60 to 77% [4, citing].
    • In cases with anasarca, the survival rate after pleural puncture is only 10 to 50% [4, citing].
  • Pleuro-amniotic Shunt (1.3):
    • The placement of a shunt allows for permanent drainage.
    • The Rodeck shunt, a double pigtail drain introduced under ultrasound control via a 3 mm trocar, is commonly used.
    • This procedure can be complicated in 15-20% of cases, mainly by premature rupture of membranes, catheter migration (to the amniotic cavity or pleural space), and chorioamnionitis [5, citing].
    • The survival rate is 50-90% depending on the presence or absence of hydrops.
  • Pleurodesis (1.4):
    • Based on adult experience, the use of OK-432 has been very rarely published in fetuses, with only about ten cases reported [6, citing].
    • One case of maternal death 8 weeks after treatment is described [6, citing].
    • The author’s personal experience includes a retrospective study of 39 hydrothorax cases from 1991-2009.

Conclusion:

  • Hydrothorax is a rare pathology that can be associated with chromosomal or other malformative or genetic anomalies, necessitating thorough antenatal investigation before offering therapy.
  • Some spontaneous resolutions have a good prognosis.
  • The survival rate for those with persistent effusion is better without anasarca (average 80% versus 50%).
  • Although no randomized studies have been conducted, the literature generally favors pleuro-amniotic shunting in severe effusions with hydrops or progression by trained teams.

The article by Romain Favre provides a comprehensive overview of the prenatal management of chylothorax, emphasizing the importance of accurate diagnosis, assessment of prognostic factors like anasarca, and the different therapeutic options available with their respective outcomes. It highlights the ongoing debates and the lack of randomized controlled trials to definitively guide management strategies.

The article “Prenatal diagnosis, imaging, and prognosis in Congenital Diaphragmatic Hernia” by Anne-Gael Cordier et al. discusses the advancements in the prenatal assessment of fetuses with Congenital Diaphragmatic Hernia (CDH), emphasizing prenatal diagnosis through ultrasound screening, the role of imaging in predicting outcome, and prognostic factors.

Introduction:

  • Prenatal ultrasound screening identifies more than 60% of Congenital Diaphragmatic Hernia (CDH) cases. This allows for in utero referral to tertiary care centers for expert assessment and perinatal management.
  • The prenatal diagnosis of CDH has improved globally since the introduction of prenatal screening ultrasound, with two-thirds of cases detected by the second trimester.
  • Ideally, detection should lead to referral to a tertiary center with experience in the perinatal management of CDH and standardized neonatal management.
  • Prenatal assessment has improved significantly over the past ten years, and the outcome can be predicted by the severity of associated conditions.

Prenatal Diagnosis:

  • CDH is characterized by the failed closure of the diaphragm, allowing abdominal viscera to herniate into the thoracic cavity, interfering with normal lung development.
  • CDH is a rare condition with a prevalence of approximately 1/4000 to 1/10,000 pregnancies. The Online Resource for Rare Diseases (ORPHA) code for CDH is 2140.
  • The defect is typically posterolateral (Bochdalek; ~70%), with rarer forms being anterior (Morgagni; ~27%) or central (~2%).
  • Bochdalek hernia is usually left-sided (LCDH; 85%), while right-sided CDH (RCDH; 13%) or bilateral (2%) are rare.
  • Prenatal diagnosis is accessible as early as the first trimester with the non-visualization of the diaphragmatic dome in the parasagittal view or the unusual visualization of the stomach in the thorax.
  • The most frequent ultrasound signs are the unusual visualization of the stomach in the thorax in left-sided CDH and/or a deviation of the heart to the right, with or without compression of the cardiac chambers.
  • The diagnosis of right-sided hernias is more difficult as the stomach remains intra-abdominal. Essential signs include deviation of the heart to the left and the presence of the liver in the thorax, potentially with the gallbladder. The absence of a satisfactory image of the right diaphragmatic dome in the parasagittal view should also raise suspicion.
  • Prenatal ultrasound should aim to confirm the diagnosis, search for associated signs (up to 40%) and individualize prognosis through genetic testing and advanced imaging.

Prenatal Imaging and Prognosis:

The article emphasizes the role of various imaging modalities and parameters in predicting the outcome of CDH:

  • Lung-to-Head Ratio (LHR):
    • The observed-to-expected lung area to head circumference ratio (O/E-LHR) is a key ultrasound parameter used for predicting survival in fetuses with isolated diaphragmatic hernia.
    • Studies have evaluated the validity of O/E-LHR in predicting outcome in the era of standardized neonatal treatment.
    • The LHR is obtained using the longest-axis method during prenatal ultrasound examination.
    • However, the reproducibility of fetal lung-to-head ratio in left diaphragmatic hernia can vary.
    • Some studies suggest that lung-to-head ratio in infants with CDH does not predict long-term pulmonary hypertension.
    • A quantitative lung index (QLI) has been proposed as a gestational age-independent sonographic predictor of fetal lung growth.
  • Fetal Lung Volume (FLV) by Ultrasound and MRI:
    • Three-dimensional ultrasonographic assessment of fetal lung volume has been studied as a prognostic factor in isolated CDH.
    • Magnetic resonance imaging (MRI) can also be used for fetal lung volume estimation. Reliability and validity of MRI lung volume measurements have been assessed.
    • Comparison of ultrasound and MRI parameters in predicting survival in isolated left-sided CDH has been performed.
    • Operator experience can impact the variability of fetal lung volume estimation by 3D-ultrasound and MRI.
    • Observed to expected total lung volume determined by MRI, based on either gestational age or fetal body volume, has been used for prenatal prediction of survival.
    • Matching by body volume or gestational age for calculating observed to expected total lung volume in fetuses with isolated CDH has been compared.
    • Correlation of observed-to-expected total fetal lung volume with intrathoracic organ herniation on MRI has been investigated.
  • Liver Herniation:
    • Fetal liver position is a significant predictor of perinatal outcome in CDH.
    • “Liver-up” (herniation of the liver into the thorax) is generally associated with a poorer prognosis.
    • Quantification of liver herniation using two-dimensional ultrasonography and MRI has been performed to predict postnatal survival.
    • The value of liver herniation in predicting outcome has been systematically reviewed.
    • The correlation between lung volume and liver herniation measurements by fetal MRI has been studied.
    • Direct and indirect sonographic assessment of liver herniation can improve the prediction of neonatal outcomes in isolated left-sided CDH.
    • Liver-to-thoracic volume ratio on MRI can predict postnatal survival, even with prenatal tracheal occlusion.
  • Stomach Position:
    • Stomach position can be a simple prognostic factor in fetal left CDH.
    • Fetal stomach position can predict neonatal outcomes in isolated left-sided CDH and is the only factor predictive of gastrointestinal morbidity at 2 years of age.
    • Stomach position versus liver-to-thoracic volume ratio in left-sided CDH has been compared.
  • Hernia Sac:
    • The presence of a hernia sac in CDH is associated with better fetal lung growth and outcomes.
    • A hernia sac may portend better survivability, especially with “Liver-Up”.
  • Pulmonary Vasculature:
    • Fetal pulmonary artery diameter measurements have been studied as a predictor of morbidity in antenatally diagnosed CDH.
    • Quantitative analysis of fetal pulmonary vasculature by 3-dimensional power Doppler ultrasonography has been performed.
    • Association between intrapulmonary arterial Doppler parameters and the degree of lung growth (measured by LHR) has been found.
    • Lung tissue perfusion, assessed by power Doppler imaging, is associated with LHR and intrapulmonary artery pulsed Doppler.
    • A prenatal pulmonary hypertension index has been proposed as a predictor of severe postnatal pulmonary artery hypertension.

Prenatal Interventions:

  • In fetuses with a predicted poor outcome, fetoscopic endoluminal tracheal occlusion (FETO) may be offered. This procedure is being evaluated in the TOTAL trial.
  • Efforts must continue to improve the quality and consistency of prenatal diagnosis and evaluation for both right and left CDH, to determine eligibility for investigational interventions like FETO and sildenafil.
  • Transplacental sildenafil administration is being investigated to reduce persistent pulmonary hypertension (PHT).

Associated Anomalies and Genetics:

  • CDH can be associated with other malformations (up to 40%) and chromosomal anomalies. This necessitates ruling out associated anomalies and individualizing prognosis.
  • In multidisciplinary prenatal diagnosis centers, the search for a tetrasomy 12p mosaic (Pallister-Killian syndrome – SPK) is requested following the discovery of a diaphragmatic hernia. However, this might overestimate the prevalence of diaphragmatic hernia in SPK.
  • The prevalence of SPK in series of diaphragmatic hernias is around 10%.
  • Genetic testing is crucial for individualizing prognosis. De novo copy number variants are associated with CDH.

Right-Sided CDH (RCDH):

  • Right-sided CDH (RCDH) is rarer than LCDH.
  • Studies have compared postnatal outcomes of right- versus left-sided CDH.
  • Quantification of liver herniation in RCDH has been performed.
  • The correlation between prenatal lung volume and postnatal survival in RCDH has been investigated.
  • Right-sided CDH may be associated with a different spectrum of associated malformations.

Postnatal Management and Follow-up:

  • Planning birth in a center experienced in perinatal CDH management with standardized neonatal management is crucial.
  • Survivors require multidisciplinary follow-up, and research linking antenatal markers for CDH-related pulmonary hypertension with long-term morbidity is still needed.
  • Postnatal care occurs in specialized high-volume tertiary centers with standardized protocols.
  • Survivors may suffer from chronic lung disease, persistent PHT, gastroesophageal reflux, feeding and growth problems, neurocognitive delay, hearing loss, thoracic deformations, and hernia recurrence.
  • Standardized postnatal management protocols exist.

Conclusion:

  • Antenatal ultrasound remains an essential tool for the diagnosis and prognostic evaluation of CDH.
  • Prenatal assessment, including imaging and genetic testing, is crucial for appropriate counseling and management.
  • The goal of prenatal evaluation is to accurately predict prognosis to guide parental decisions regarding expectant management, termination of pregnancy, or fetal intervention in selected cases.
  • Further research is needed to improve prenatal prediction and long-term outcomes for infants with CDH.

The article provides a comprehensive overview of the prenatal aspects of CDH, highlighting the importance of early diagnosis, thorough imaging, and the consideration of various prognostic factors to optimize management and outcomes.

The article by Desseauve et al. focuses on the prenatal diagnosis of Pallister-Killian syndrome (PKS), a rare genetic disorder, through a retrospective multicenter study of 10 cases (6 with detailed prenatal ultrasound data) and a review of the literature. The authors aim to define prenatal clues that can suggest PKS beyond the classically associated diaphragmatic hernia.

Introduction:

  • Pallister-Killian syndrome (PKS) is a rare disease with a prevalence estimated at 1/20,000 births. This incidence is likely underestimated due to difficulties in cytogenetic diagnosis from standard blood samples.
  • PKS is caused by a tissue mosaicism of tetrasomy of the short arm of chromosome 12 (12p). Homogeneous forms (affecting all cells) are lethal at the embryonic stage.
  • The isochromosome 12p is likely of paternal origin and results from a post-zygotic event.
  • Generally, in multidisciplinary prenatal diagnosis centers, mosaic tetrasomy 12p is primarily investigated upon the prenatal discovery of a diaphragmatic hernia. Other anomalies do not systematically trigger specific cytogenetic testing for PKS.
  • Consequently, existing series of PKS cases may overestimate the prevalence of diaphragmatic hernia in this syndrome at the expense of other morphological abnormalities.
  • This study aims to define prenatal warning signs that can suggest PKS beyond the classic diaphragmatic hernia, based on a cohort of fetuses with cytogenetically confirmed PKS, by comparing antenatal and fetopathological findings and by a literature review of antenatal PKS cases since 2002.

Methods:

  • The study is a retrospective and multicenter case series.
  • A call for collaboration was made to all members of the French Society of Fetopathology (SOFFOET) to identify PKS cases with fetopathological examination over the past 15 years.
  • For each identified case, prenatal and postnatal data were collected, including pregnancy records, morphological ultrasounds, cytogenetic results, and fetopathology reports.
  • Antenatal data were compared with fetopathological data to evaluate the relevance of sonographic signs of PKS.
  • A non-exhaustive literature review on antenatal morphological anomalies in PKS cases since 2002 was conducted using the PubMed database with keywords: chromosome, human, 12, pallister-killian syndrome.
  • Data were listed and classified by frequency (purely descriptive analysis due to the expected small sample size).

Results:

  • Ten cases were reported, of which 7 had cytogenetic confirmation of PKS.
  • Four cases were excluded (3 without cytogenetic analysis, 1 without prenatal ultrasound). Six cases were included in the study with available prenatal ultrasound data.
  • The 6 included cases consisted of 5 medical terminations of pregnancy (IMG) and 1 intrauterine fetal death (MFIU), with a mean gestational age at fetopathological examination of 20 weeks of gestation (range: 17-24 weeks).
  • All 6 cases with prenatal ultrasound had been referred to a multidisciplinary prenatal diagnosis center.
  • For one case (no. 6), IMG was performed without prior prenatal karyotyping due to the severity of polymalformative syndrome detected on prenatal ultrasound.
  • Among the included fetuses, 4/6 were female.
  • Prenatal ultrasound findings:
    • The most frequent finding was craniofacial dysmorphism (5/6 cases), including broadened nasal bridge (3/6), long philtrum (2/6), and hypertelorism (2/6).
    • Limb malformations were reported in half of the cases (3/6), including one case of rhizomelic micromelia (femur < 5th percentile).
    • Visceral malformations were less frequently reported (3/6 cases) and were diverse. One case (no. 6) presented with polymalformative visceral anomalies.
    • No case of diaphragmatic hernia was diagnosed prenatally in this series.
  • Fetopathological examination corresponded to ultrasound findings for sex and absence of intrauterine growth restriction (IUGR) in all cases.
  • Facial dysmorphic features were evident in 5/6 cases on ultrasound. Long philtrum and hypertelorism, as well as limb malformations, were detected in half of the cases prenatally.
  • Visceral malformations were reported in slightly more than half of the fetopathological examinations (4/7). Specific findings included broadened nasal bridge (5/6), long philtrum (5/6), camptodactyly (4/6), hypertelorism (4/6), poorly folded ears (4/6), and single transverse palmar crease (3/6). One case of left diaphragmatic hernia was found post-mortem. No cases showed IUGR. Eight visceral malformations were noted on fetopathology (esophageal atresia, single umbilical artery, pyelocaliceal dilation, agenesis of the gallbladder, renal cysts, esophageal atresia, and two lung lobulation anomalies), of which four had been seen on ultrasound. Two urogenital malformations were discovered at autopsy in two girls, not seen on ultrasound.
  • Literature Review:
    • Seventeen cases of PKS with prenatal evaluation were identified in the literature since 2002. This brought the total number of prenatally evaluated cases to 79 by 2016.
    • The most frequently reported ultrasound anomalies since 2002 were thickened nuchal translucency (57%), craniofacial malformations, micromelia (52%), hydramnios, and poorly/non-visualized stomach (22% of cases).
    • Diaphragmatic hernias were reported in 17% of the cases published since 2002.

Discussion:

  • While diaphragmatic hernia is a classic antenatal finding in PKS, other signs like hydramnios, craniofacial dysmorphism (flat profile, long philtrum, and hypertelorism), limb malformations (micromelia) or extremity anomalies, without IUGR, are also regularly associated with PKS.
  • In this case series, diaphragmatic hernia was found in only one case. Although it often prompts prenatal investigation for PKS, it could represent a differential confounding bias in the malformative spectrum of PKS. As it is a primary reason for PKS diagnosis, its prevalence might be overestimated. The low prevalence of PKS in diaphragmatic hernia series (around 10%) also supports this.
  • The study’s cohort, consisting of terminated pregnancies or intrauterine fetal deaths, likely represents more severe PKS cases compared to live births, which might present with less severe, unnoticed malformations or those not justifying IMG. Intellectual disability, developmental delays, facial dysmorphism (Pallister lip), and epilepsy are more regularly reported in living PKS cohorts.
  • The limited sample size of this study compared to the broader literature review by Doray et al. is a limitation, hence the complementary literature review to refine the malformative spectrum of PKS. However, this study is one of the largest consecutive series with results directly from ultrasound and fetopathology reports, reducing publication bias.
  • Hydramnios is the most frequently reported sign in the literature, but its pathophysiology in PKS remains unclear. Esophageal atresia, a potential cause of hydramnios, is rarely associated with PKS and did not correlate with hydramnios in this series.
  • The 30% incidence of diaphragmatic hernia in PKS reported by Doray et al. was not changed by this literature review. The single case in this series suggests that relying solely on diaphragmatic hernia for PKS diagnosis might be misleading.
  • Other anomalies like single transverse palmar creases or ear anomalies, frequently reported in these PKS cases, are difficult to assess on ultrasound.
  • The study confirms, consistent with the literature, the absence of IUGR in PKS and a tendency towards macrosomia. However, some cases report early IUGR.
  • In the absence of highly specific ultrasound signs for PKS, this series and literature review show a broad use of karyotyping in cases of polymalformative syndrome. Molecular karyotyping (CGH array) is now widely used and allows diagnosis in most cases due to the generally significant mosaicism rate in amniocytes. However, it may miss low-level mosaicism, leading to rare false negatives. In such cases, suggestive ultrasound signs – micromelia, characteristic face (long philtrum and hypertelorism), diaphragmatic hernia without IUGR – should raise suspicion. 3D facial ultrasound can aid in differential diagnosis from Fryns syndrome, especially with diaphragmatic hernia. The absence of RCIU (common in Fryns) should also point towards PKS in cases with face, limb, and diaphragm anomalies.

Conclusion:

  • The literature suggests certain malformation associations indicative of PKS, but it remains challenging to suspect this syndrome on ultrasound in a fetus with normal weight, facial and limb involvement, without the classic diaphragmatic hernia.
  • Advances in ultrasound and 3D imaging may improve the precision of diagnosing this syndrome with a broad antenatal malformative spectrum.
  • Similarly, the increasing use of molecular karyotyping in atypical malformation associations will be beneficial.

The article by Basurto et al. in Best Practice & Research Clinical Obstetrics and Gynaecology provides a comprehensive overview of the prenatal diagnosis and management of congenital diaphragmatic hernia (CDH). CDH is characterized by the failed closure of the diaphragm, allowing abdominal viscera to herniate into the thoracic cavity, thereby interfering with normal lung development. This leads to pulmonary hypoplasia and persistent pulmonary hypertension (PHT) at birth, which can be lethal in up to 32% of patients.

The authors highlight that in isolated cases, the outcome may be predicted prenatally by medical imaging and advanced genetic testing. Prenatal ultrasound screening identifies more than 60% of CDH cases, typically by the second trimester. This early diagnosis is crucial as it provides the opportunity for in utero referral to a tertiary care center for expert assessment and perinatal management. The goal of prenatal assessment is to rule out associated anomalies (up to 40%) and individualize prognosis through genetic testing and advanced imaging. This information allows parents to make informed decisions regarding expectant management with prenatal referral for elective delivery, termination of pregnancy, or fetal intervention in selected cases. The defect is most commonly posterolateral (Bochdalek, ~70%) and usually left-sided (LCDH, 85%), with right-sided (RCDH, 13%) and bilateral (2%) hernias being rarer. Rarer forms include anterior (Morgagni, ~27%) and central (~2%) hernias.

Prenatal diagnosis often involves ultrasound which can reveal the herniation of abdominal organs into the thorax, potentially showing the stomach in the thorax in left-sided CDH, or the liver in right-sided CDH, as well as a mediastinal shift and compression of the heart. The lung-to-head ratio (LHR), calculated using ultrasound, is a key prognostic factor. Advances in prenatal imaging, including magnetic resonance imaging (MRI), allow for a more accurate assessment of fetal lung volume and the degree of liver herniation. The observed-to-expected total fetal lung volume (O/E TLV), often determined by MRI, has become an important predictor of survival. The position of the stomach and liver, assessed by ultrasound, can also provide prognostic information. The presence of a hernia sac has been associated with better fetal lung growth and outcomes. Doppler studies of the fetal pulmonary vasculature are also used to assess the risk of postnatal pulmonary hypertension.

For fetuses with a predicted poor outcome, fetoscopic endoluminal tracheal occlusion (FETO) may be offered. This procedure aims to improve lung development by temporarily obstructing the trachea, leading to fluid accumulation in the lungs. The TOTAL trial is a global randomized clinical trial evaluating FETO. The article also mentions the investigation of alternative strategies, including transplacental sildenafil administration, to reduce the occurrence of persistent PHT.

At birth, infants with CDH require management in specialized high-volume tertiary centers with standardized protocols. Despite optimal neonatal care, mortality remains around 30%. Survivors may suffer from chronic lung disease, persistent PHT, gastroesophageal reflux, feeding and growth problems, neurocognitive delay, hearing loss, thoracic deformations, and hernia recurrence. Therefore, multidisciplinary follow-up is essential for survivors.

The authors emphasize the importance of continuous efforts to improve the quality and consistency of prenatal diagnosis and evaluation for both right and left CDH. Research linking antenatal markers for CDH-PH with long-term morbidity is still needed. Standardized prenatal ultrasound assessment protocols have been proposed by the European reference network on rare inherited and congenital anomalies (ERNICA).

In conclusion, the article underscores the advancements in prenatal diagnosis and management of CDH, highlighting the critical role of early detection, comprehensive prenatal assessment for prognosis and associated anomalies, and the potential for fetal interventions like FETO in selected severe cases. Optimal postnatal care in specialized centers and long-term multidisciplinary follow-up are crucial for improving outcomes for infants with CDH.

The article, written by H. Bouchghoul et al., provides a methodological guide on performing an ultrasound scan on a fetus with a congenital diaphragmatic hernia (CDH). The authors emphasize that while prenatal diagnosis of CDH is feasible from the first trimester, the key challenges lie in confirming the diagnosis, identifying associated anomalies, and evaluating the prognosis to optimize prenatal counseling. The goal of prognostic evaluation is also to select fetuses eligible for in utero fetal therapy. Delivery should be planned in a type 3 maternity unit equipped for specialized care of CDH.

Diagnostic Ultrasound Examination:

The article outlines a structured approach to the ultrasound examination of a fetus suspected of having CDH.

  • Confirmation of CDH Diagnosis:
    • In the first trimester, CDH can be suspected by the non-visualization of the diaphragmatic dome in the parasagittal view or the unusual visualization of the stomach in the thorax.
    • More frequently, the diagnosis is made in the second trimester based on characteristic ultrasound findings.
    • Left-sided CDH (LCDH) is suggested by the unusual visualization of the stomach in the thorax and/or a deviation of the heart to the right, potentially with compression of the cardiac chambers.
    • Right-sided CDH (RCDH) is more challenging to diagnose as the stomach remains intra-abdominal. Key signs include deviation of the heart to the left and the presence of the liver in the thorax, possibly with the gallbladder. Suspicion should also arise from the absence of a satisfactory image of the right diaphragmatic dome in the parasagittal view.
  • Assessment of Associated Malformations:
    • CDH is associated with other morphological, cytogenetic, or genetic anomalies in up to 35% of cases.
    • A detailed morphological ultrasound should be performed to look for associated malformations, particularly cardiac (18%), renal, limb, and vertebral (10%) anomalies, although any organ can be affected.
    • Amniocentesis with fetal karyotype analysis and ACPA (presumably array comparative genomic hybridization) are indispensable.
    • Certain chromosomal abnormalities are more frequent, such as trisomy 18 and deletions of chromosomes 8 or 15.
    • Tetrasomy 12p (Pallister-Killian syndrome) should be systematically investigated, but the search requires a direct preparation (trophoblast or amniotic cells) due to the risk of false negatives in cultured cells.
    • CDH is also associated with numerous genetic syndromes (e.g., Fryns, Donnai-Barrow, Matthew-Woods, Simpson-Golabi, Perlman, Denys-Drash).
  • Prognostic Evaluation: The article details several ultrasound parameters used for prognostic evaluation.
    • Lung-to-Head Ratio (LHR):
      • LHR is an indirect measure of pulmonary hypoplasia.
      • It is the ratio between the contralateral lung area (measured on a strictly axial view showing the four cardiac chambers) and the head circumference.
      • The contralateral lung area can be measured in three ways: multiplication of the two largest diameters, multiplication of the anteroposterior diameter and its perpendicular diameter, or tracing its contour (the most reproducible and recommended technique). Multiplication of the largest diameters can also be used.
      • The observed LHR is then related to the expected LHR for the gestational age, resulting in the observed/expected LHR (O/E-LHR), which is interpretable regardless of gestational age.
      • An algorithm for calculating O/E-LHR is available online and via a mobile application (CDH Calculator).
      • O/E-LHR is correlated with postnatal morbidity and mortality, with severe forms defined by lower values (e.g., O/E-LHR < 25%).
  • Liver Position:
      • The position of the liver in relation to the diaphragm is a crucial prognostic factor.
      • Ascension of the liver into the thorax (liver-up) indicates a more severe prognosis than when the liver remains in the abdomen (liver-down).
      • Liver herniation can be assessed by ultrasound, identifying the passage of the umbilical vein through the diaphragm.
      • Magnetic Resonance Imaging (MRI) can provide a more precise quantification of the volume of the liver herniated into the thorax.
  • Stomach Position (in LCDH):
      • The position of the stomach in the thorax in cases of left-sided CDH is also a prognostic factor.
      • A classification system grades stomach position from Grade 1 (stomach not visualized in the thorax) to Grade 4 (stomach posterior to the level of the atrioventricular heart valves).
      • A more caudal position of the stomach (lower grade) is generally associated with a better prognosis.
      • Presence of the stomach in the abdomen in LCDH is a very good prognostic sign, indicating that only the intestines have herniated and the liver remains abdominal.
  • Fetal Heart Examination:
      • Examination of the fetal heart is challenging in CDH due to compression of the cardiac chambers, especially the left side.
      • There is an increased risk of associated cardiac anomalies (11-15%) in CDH, most commonly atrial and ventricular septal defects, conotruncal anomalies, and left ventricular outflow tract obstructions.
      • The association of a cardiac malformation worsens the prognosis.

The authors conclude that a thorough prenatal ultrasound evaluation of CDH is necessary to refine the prognosis and provide appropriate prenatal counseling. While several prenatal prognostic tools exist, including ultrasound, no single factor is 100% reliable for predicting postnatal outcome. However, a combination of prenatal factors allows for establishing a likely prognosis. Fetal thoracic MRI can also be used for prognostic evaluation by assessing the observed/expected lung volume and the volume of liver herniation. Despite the advancements, ultrasound remains an essential examination for guiding parents and referring them to specialized centers for consideration of in utero fetal therapy. The role of fetal therapy remains controversial due to limitations in study power and control groups.

The article by Darouich and Bellamine presents a case report of a fetal mediastinal teratoma that was initially misinterpreted as congenital cystic lesions of the lung on prenatal ultrasound. The authors highlight that while teratomas are among the most common congenital tumors, thoracic teratomas can be challenging to diagnose prenatally and may be confused with other conditions such as congenital adenomatoid malformation of the lung, bronchogenic cysts, diaphragmatic hernia, or bronchopulmonary sequestration. The case underscores the importance of careful Doppler ultrasound assessment for accurate prenatal diagnosis and fetal outcome evaluation.

Case Report:

The case involved a 31-year-old patient, gravida 2, para 2, who was referred at 23 weeks gestation for investigation of fetal hydrops. The patient had no history of gestational diabetes or abnormal glucose tolerance, and her blood group was A positive. A first morphology ultrasound at 17 weeks gestation was unremarkable.

At 23 weeks, ultrasound revealed severe fetoplacental hydrops, moderate posthemorrhagic hydrocephalus, and multiple pulmonary cysts suggesting cystic adenomatoid malformation. The heart was also noted to be displaced to the left side. Due to these findings, a congenital cystic adenomatoid malformation was suspected in a male fetus with a normal karyotype.

However, autopsy of the hydropic 24-week male fetus revealed a large cystic-solid mediastinal mass consistent with a nonmetastatic immature teratoma. The autopsy also demonstrated thymic, cardiac, and pulmonary hypoplasia, and confirmed the germinal matrix-intraventricular hemorrhage. Additionally, placental diffuse multifocal chorangiomatosis was observed.

Discussion:

The authors emphasize that mediastinal teratoma is a life-threatening tumor due to associated fetoplacental complications. In this case, a large cystic and solid immature mediastinal teratoma was prenatally interpreted as a congenital cystic adenomatoid malformation.

The article notes that prenatal diagnosis of mediastinal teratoma can usually be made using two-dimensional ultrasonography as the mass often exhibits both cystic and solid components, along with calcification spots and acoustic shadows. However, as seen in this case, large masses occupying the entire thoracic cavity can be misinterpreted as bronchogenic cysts, congenital cystic adenomatoid malformation of the lung, diaphragmatic hernia, or bronchopulmonary sequestration. Retrospective reevaluation of the ultrasound imaging in this case also revealed a hyperechoic linear plaque of calcification with acoustic shadowing within the mass, which are characteristic features of teratomas.

The presence of periventricular echogenic areas with moderate dilatation of the lateral ventricle on ultrasound suggested posthemorrhagic hydrocephalus, which was confirmed by autopsy as germinal matrix intraventricular hemorrhage. The authors suggest that decreased cardiac output, likely due to compression by the mediastinal mass, can lead to rupture of the sensitive capillaries in the germinal matrix, causing hemorrhage. Ultrasound also clearly demonstrated a large placenta, and increased umbilical artery systolic/diastolic ratio detected by Doppler velocimetry can indicate substantial compression of the cardiovascular system.

The authors conclude that accurate prenatal diagnosis of mediastinal teratoma may be achieved through careful Doppler ultrasound assessment, which also allows for evaluating the fetal outcome. This case highlights the challenges in differentiating mediastinal teratoma from other congenital thoracic lesions on prenatal ultrasound and emphasizes the importance of considering teratoma in the differential diagnosis of fetal cystic lung lesions, especially when associated with hydrops and mediastinal shift.

The article also refers to literature indicating that ultrasonography has high sensitivity and low false-positive rates in identifying fetal teratoma. However, the potential for misinterpretation, as demonstrated in this case, necessitates a thorough evaluation including the search for characteristic features like calcifications and a comprehensive assessment of the surrounding structures and potential signs of compression.

The article by Ruchonnet-Metrailler et al. investigates the neonatal respiratory outcomes of congenital pulmonary malformations (CPM) that were primarily identified prenatally. The authors note that while CPM are frequently detected during routine second-trimester ultrasound examinations, the factors predicting which newborns will develop respiratory distress at birth are not well-defined. Understanding these predictive factors is crucial for determining the appropriate level of care and delivery location for these pregnancies, ideally in a tertiary care center.

Background and Objectives:

The authors highlight that CPM encompass various histologic entities, with congenital cystic adenomatoid malformations being the most frequent. While many children with CPM are asymptomatic at birth, some experience respiratory distress severe enough to necessitate mechanical ventilation and immediate surgery. The study aims to identify potential prenatal parameters predictive of respiratory distress in neonates with CPM. This knowledge is essential for optimizing the care pathway following prenatal diagnosis.

Methods:

The study utilized data from RespiRare, the French prospective multicenter registry for liveborn children with rare respiratory diseases, collected between 2008 and 2013. The researchers selected cases with a prenatal diagnosis of hyperechoic and/or cystic lung lesions. They then correlated prenatal parameters with the neonatal respiratory outcome.

The prenatal data collected included: gestational age at diagnosis, appearance of the lesion (size, location, type), associated abnormalities (mediastinal shift, polyhydramnios defined as an amniotic fluid index greater than the 90th percentile, or hydrops). Neonatal data included: gestational age at delivery, birth weight, and respiratory status (tachypnea defined as a respiratory rate >60 inspirations per minute, chest wall retraction, need for oxygen supplementation or ventilation). Lesions were classified as cystic (diameter >5 mm), hyperechoic, or mixed.

Maximum prenatal malformation area (calculated from the two largest dimensions) and maximum congenital pulmonary malformation volume ratio (CVR) were analyzed for a subgroup of patients (n=50) from the center with the largest number of cases, where this data was reliably available. CVR was estimated using the formula for an ellipsoid: length × height × width × π/6, divided by the head circumference.

Results:

Data from 89 children were analyzed, of whom 22 (25%) had abnormal breathing at birth, and 12 (13%) experienced severe respiratory distress requiring oxygen supplementation or ventilatory support.

The study found that respiratory distress at birth was significantly associated with the following prenatal parameters:

  • Mediastinal shift (P = .0003)
  • Polyhydramnios (P = .05)
  • Ascites (P = .0005)
  • Maximum prenatal malformation area (P = .001)
  • Maximum congenital pulmonary malformation volume ratio (CVR) (P = .001)

Limiting the analysis to the subgroup with severe respiratory distress requiring oxygen supplementation (n=12) yielded similar significant associations with the prenatal signs of compression, mediastinal shift, polyhydramnios, ascites, maximum malformation area, maximum malformation volume, and maximum CVR.

Receiver operating characteristic (ROC) curve analysis showed that a CVR cutoff of 0.84 yielded the highest significance for predicting the need for oxygen at birth, with a sensitivity of 0.87 and a specificity of 0.81 (P = .0006). The area under the ROC curve was 0.804.

Interestingly, apparent regression of the CPM during the third trimester did not affect oxygen requirement at birth. Furthermore, polyhydramnios, ascites, and a maximum CVR >0.84 were more reliable predictors of oxygen requirement at birth than mediastinal shift. For predicting the need for oxygen, specificity was highest for the prenatal detection of polyhydramnios and/or ascites, while sensitivity was highest for a maximum CVR >0.84.

Conversely, a low CVR was significantly associated with the absence of oxygen requirement at birth (odds ratio: 0.02 [95% confidence interval: 0.001–0.58]; P < .03).

Conclusions:

The authors conclude that maximum CVR and prenatal signs of intrathoracic compression are significant risk factors for respiratory complications at birth in fetuses with CPM. Specifically, a CVR >0.84, polyhydramnios, and ascites were significantly associated with more severe respiratory distress requiring at least oxygen supplementation. In such situations, the authors recommend that delivery should be planned at a tertiary care center.

The study highlights the importance of these prenatal ultrasound parameters in predicting neonatal respiratory outcomes in CPM and emphasizes the need for delivery in specialized centers for cases with high CVR or signs of fetal compression.

The article by Wong et al. explores the concordance between prenatal ultrasound findings of hyperechoic lung lesions and postnatal diagnoses based on CT scans, highlighting the challenge of accurately diagnosing the underlying etiology of such lesions prenatally. The study emphasizes that while hyperechoic lung lesions are frequently detected, their non-specific appearance makes definitive prenatal diagnosis difficult, impacting prenatal counseling and perinatal management.

Background and Objectives:

The authors note that prenatal ultrasound commonly detects hyperechoic lung lesions, which can represent a spectrum of congenital lung malformations, including bronchopulmonary sequestrations (BPS), pulmonary cystic malformations (PCM), congenital lobar emphysemas (CLE), bronchogenic cysts (BC), and hybrid malformations. Given that postnatal CT scans have demonstrated higher diagnostic accuracy than ultrasound and MRI, they are considered the gold standard for final diagnosis. The aim of this retrospective study was to determine the concordance between prenatal ultrasound diagnoses of hyperechoic lung lesions and the corresponding postnatal diagnoses established by CT scan or histological examination. The ultimate goal was to provide parents with more reliable, evidence-based information during prenatal counseling and to optimize perinatal management by ensuring delivery in appropriate birthing centers.

Methods:

This was a retrospective study conducted at a single institution, including all patients diagnosed prenatally with hyperechoic lung images between January 2009 and December 2018. Prenatal ultrasound evaluations were performed by fetal medicine specialists. Postnatal diagnoses were primarily based on CT scans, with histological examination used in some cases. Information on pre- and postnatal periods, as well as imaging findings, were retrieved from medical charts.

The study analyzed various prenatal ultrasound features, including the presence of cystic components and mediastinal shift. The prenatal detection of a systemic arterial supply was also noted. Neonatal symptoms, such as respiratory distress requiring oxygen assistance, were recorded. Postnatal diagnoses were categorized as BC, PCM, CLE, BPS, or hybrid malformations. The researchers then assessed the concordance between these prenatal findings and postnatal diagnoses.

Results:

A total of 75 patients with prenatal hyperechoic lung lesions were included in the study. The main prenatal ultrasound diagnoses were BPS (24%-32%), PCM (19%-25%), and CLE (15%-20%). Mediastinal shift was observed in 18 cases (24%).

The study found that:

  • The prenatal detection of a systemic arterial supply had a high diagnostic accuracy of 90%.
  • The prenatal detection of a cystic component had a lower diagnostic accuracy of 76.5%, indicating that hyperechoic lesions on prenatal ultrasound do not reliably predict the presence of cystic components postnatally.
  • None of the 16 neonates with isolated prenatal mediastinal shift developed neonatal symptoms. This suggests that isolated prenatal mediastinal shift in hyperechoic lung lesions may not be associated with a higher risk of neonatal morbidity.
  • Seven neonates (9%) showed unexpected respiratory distress that was not predicted prenatally. Among these, the postnatal diagnoses were CLE (5 cases), BC (1 case), and BPS (1 case).
  • Prenatal compressive signs necessitating intervention (cystic-amniotic shunt in one case of bronchogenic cyst) were associated with postnatal symptoms.
  • During follow-up, respiratory symptoms like recurrent bronchiolitis or asthma were common, and lung infections were more frequent in cases with a BPS component.

Conclusions:

The authors concluded that prenatal ultrasound detection of hyperechoic lung malformations reflects a heterogeneous group of lesions with good concordance for bronchopulmonary sequestration when a systemic arterial supply is identified. However, the ability to accurately predict cystic components postnatally based on prenatal hyperechoic images is limited.

The study also suggests that isolated prenatal mediastinal shift in the context of hyperechoic lung lesions may not be a reliable predictor of neonatal respiratory distress. The authors emphasize that the absence of compression signs on prenatal ultrasound does not guarantee the absence of neonatal respiratory distress.

Overall, this study highlights the challenges in achieving definitive prenatal diagnoses of hyperechoic lung lesions and underscores the importance of postnatal CT imaging for accurate classification and appropriate long-term management. The findings contribute to better informed prenatal counseling by providing data on the concordance between prenatal ultrasound findings and postnatal diagnoses of these complex fetal anomalies.

The article by Delacourt et al. presents the findings of the MALFPULM study, a national, multicenter, prospective cohort study conducted in France to assess the prenatal natural history of congenital pulmonary malformations (CPM). The study specifically aimed to evaluate changes in CPM volume over gestation and to determine if these changes differ between lesions appearing cystic versus hyperechoic on ultrasound. Furthermore, it investigated the relationship between CPM volume, quantified by the congenital pulmonary malformation volume ratio (CVR), and the risk of fetal compression.

Background and Objectives:

The authors emphasize that while ultrasound is the primary modality for prenatal diagnosis of CPM, the histological diagnosis often remains uncertain based solely on ultrasound findings. CPM encompass various entities like congenital cystic adenomatoid malformations (CCAM), sequestrations, bronchial atresia, congenital lobar emphysema, and bronchogenic cysts.

A key concern with CPM is the risk of fetal compression due to the lesion’s volume, which can lead to mediastinal shift, diaphragm eversion, polyhydramnios, ascites, and even hydrops. The CVR has been developed as an indicator of mass size to predict prenatal complications and neonatal respiratory distress, as discussed in the Ruchonnet-Metrailler et al. article we previously summarized. The current study addresses the lack of prospective, population-based data on the intrauterine growth patterns of CPM and their determinants, which complicates clinical decision-making for optimal fetal follow-up and treatment.

Methods:

The MALFPULM study is a nationally representative cohort recruiting pregnant women with a prenatal diagnosis of fetal CPM from 37 Multidisciplinary Centers for Prenatal Diagnosis (MCPD) in France between March 2015 and November 2016. The study included 579 ultrasound examinations in 176 women. Several ultrasound examinations were performed between diagnosis and delivery, including measurement of CPM volume.

CPM volume was estimated using the formula for an ellipsoid (length × width × height × π/6), and the CVR was calculated by dividing the CPM volume by the estimated fetal head circumference. Changes in CVR were modeled as a function of gestational age, both overall and separately for cystic/mixed versus hyperechoic malformations. The association between CVR and signs of compression (mediastinal shift, polyhydramnios, ascites, hydrops) during pregnancy was also examined. Standardized definitions for CPM types based on ultrasound characteristics were used.

Results:

The study included 176 women with a mean of 4.4 ultrasound examinations per woman. The cohort comprised 90 (51%) hyperechoic CPMs and 86 (49%) cystic/mixed CPMs. Systemic vascularization was noted in 56 (32%) CPMs at some point during pregnancy. At least one sign of compression was observed in 80 (45%) fetuses.

Key findings regarding the natural history of CPM volume:

  • The mean CVR showed a decrease over gestational age for the entire cohort.
  • Hyperechoic CPMs had a higher initial CVR at the first ultrasound examination but showed a steeper decline in CVR over gestation compared to cystic/mixed CPMs. This aligns with previous observations of potential regression of hyperechoic lesions, as mentioned in the Wong et al. summary regarding “vanishing” lung malformations.
  • The presence of systemic vascularization in hyperechoic CPMs did not significantly affect the pattern of CVR change over time.

Regarding the association between CVR and fetal compression:

  • A strong association was found between initial CVR and the risk of compression. The adjusted odds of compression were 17.3-fold higher when the initial CVR was > 0.4 cm² compared to ≤ 0.4 cm² for the overall study population.
  • Even in the subgroup of fetuses with no initial signs of compression, the adjusted odds of developing compression were 7.0-fold higher when the initial CVR was > 0.4 cm².

Conclusions:

The authors conclude that CPM volume, as measured by CVR, tends to decrease over gestational age, with hyperechoic lesions showing a more pronounced decrease than cystic/mixed lesions. This provides valuable information on the expected prenatal evolution of these malformations.

Crucially, the study confirms a strong association between a higher initial CVR and an increased risk of fetal compression, even in cases without initial compressive signs. This highlights the prognostic significance of CVR in predicting potential complications during pregnancy. The findings underscore the importance of serial ultrasound monitoring of CPM volume to assess the risk of fetal compression and inform clinical management. The use of standardized ultrasound definitions for CPM types strengthens the reliability of the study’s conclusions.

This population-based, prospective study provides more precise and reliable data on the prenatal natural history of CPM than previous smaller, retrospective studies, aiding in better prenatal counseling and management of pregnancies complicated by these fetal anomalies.

The article by A. G. Cordier et al. investigates the long-term gastrointestinal morbidity (GIM) in children with isolated left-sided congenital diaphragmatic hernia (CDH) and evaluates the predictive value of prenatal stomach position on this morbidity at 2 years of age. This study acknowledges that while survival rates for CDH have improved, long-term morbidity, particularly related to gastrointestinal issues, remains a significant concern.

Background and Objectives:

The authors highlight that gastroesophageal reflux and oral aversion affect a large proportion of children with left-sided CDH and can persist as major problems at 2 years of age. Despite the well-described long-term morbidity, the prenatal factors that predict these specific outcomes are not fully understood. Previous research has focused on prenatal predictors of survival, such as the observed-to-expected lung-area-to-head-circumference ratio (O/E-LHR) and liver position. This study specifically aims to evaluate the effect of fetal stomach position on the risk of GIM at 2 years in children with isolated left-sided CDH, both with and without prior fetal endoscopic tracheal occlusion (FETO).

Methods:

This was a retrospective, observational multi-center cohort study conducted between January 2010 and January 2014. The study included 47 patients whose fetuses had isolated left-sided CDH and for whom prenatal ultrasound images at the level of the four-chamber view of the heart and O/E-LHR measurements were available. Patients with associated malformations, chromosomal abnormalities, right-sided or bilateral CDH, medical termination of pregnancy, or death before 2 years of age were excluded.

Fetal stomach position was evaluated a posteriori by two observers using the same ultrasound images used for LHR measurement. The stomach position was graded into four categories:

  • Grade 1: Stomach not visualized.
  • Grade 2: Stomach visualized anteriorly, next to the apex of the heart, with no structure in between the stomach and the sternum.
  • Grade 3: Stomach visualized alongside the left ventricle of the heart, with abdominal structures anteriorly.
  • Grade 4: Similar to Grade 3 but with the stomach posterior to the level of the atrioventricular heart valves.

The primary outcome was GIM at 2 years of age, assessed in a composite manner including the occurrence of gastroesophageal reflux disease (GERD), need for gastrostomy, duration of parenteral and enteral nutrition, and persistence of oral aversion. Regression analysis was performed to investigate the effect of O/E-LHR, stomach position, and FETO on various GIM outcome variables. Postnatal management followed national recommendations.

Results:

At 2 years of age, 13 out of 47 infants (27.7%) did not meet the criterion of exclusive oral feeding. The study found a significant and independent association between fetal stomach position grade and the duration of parenteral nutrition (higher grade associated with longer duration) and the persistence of oral aversion at 2 years (higher grade associated with increased risk).

Specifically:

  • Grade 1 (Stomach not visible): 10 cases.
  • Grade 2 (Anterior stomach): 17 cases.
  • Grade 3 (Lateral stomach): 12 cases.
  • Grade 4 (Posterior stomach): 8 cases.

The median O/E-LHR decreased with increasing fetal stomach position grade. O/E-LHR was predictive of the need for prosthetic patch repair but not for GIM. FETO did not appear to affect the risk of GIM at 2 years. Fetal stomach position was an independent predictor of the length of stay in the neonatal intensive care unit and the total duration of hospitalization. Approximately one-quarter of children had GERD, and nearly half had oral aversion at 2 years. The risk of oral aversion increased with higher fetal stomach position grades.

Conclusions:

The authors concluded that in isolated left-sided CDH, fetal stomach position is the only factor that is predictive of GIM at 2 years of age. Specifically, a more superiorly positioned fetal stomach (higher grade) was associated with a higher risk of prolonged parenteral nutrition and persistent oral aversion. This finding suggests that prenatal ultrasound assessment of fetal stomach position can provide valuable information for predicting long-term gastrointestinal outcomes in these children. The study emphasizes that this simple, reliable, and reproducible marker can be used to standardize information given to parents regarding postnatal prognosis and to improve the follow-up care for children with left-sided CDH. While O/E-LHR remains important for predicting pulmonary outcomes and the need for surgical repair, fetal stomach position appears to be a key prenatal indicator for long-term gastrointestinal morbidity. The authors acknowledge the study’s limitations, including its retrospective nature and small sample size, and suggest the need for larger prospective studies to confirm these findings.

Prenatal Diagnosis of Corpus Callosum Anomalies

Overview

  1. Introduction

The corpus callosum (CC), the largest commissural tract in the human brain, plays a vital role in interhemispheric communication and integration of motor, sensory, and cognitive information. Anomalies of the corpus callosum—ranging from complete or partial agenesis to dysplasia, hypoplasia, or hyperplasia—are among the most frequently diagnosed brain malformations in fetal medicine.

The prenatal diagnosis of CC anomalies remains a clinical and diagnostic challenge due to:

  • The complex embryology of the CC
  • The variability in imaging quality and timing
  • The heterogeneity in terminology and classification
  • The diversity of neurodevelopmental outcomes

This synthesis integrates findings from ten recent articles, including original cohort studies, meta-analyses, systematic reviews, and narrative reviews, to provide a multidimensional overview of current evidence surrounding prenatal CC anomalies.

  1. Embryology and Classification of Corpus Callosum Anomalies

The CC begins developing around the 10th week of gestation and continues until term, with anterior-to-posterior formation (genu → body → splenium). By 18–20 weeks, its four anatomical segments—rostrum, genu, body, and splenium—are typically identifiable on imaging.

Anomalies are classified into five major categories:

  • Complete agenesis (cACC): absence of all CC segments
  • Partial agenesis (pACC): absence of one or more segments (usually posterior)
  • Hypoplasia: underdevelopment of a fully formed CC
  • Hyperplasia: abnormally thick CC (rare)
  • Dysgenesis: structurally abnormal CC with irregular morphology

Terminological inconsistency remains problematic, as highlighted by Mahallati et al., with the same findings variably labeled as hypoplasia, dysgenesis, or partial agenesis across studies. Standardization is needed to ensure consistent communication and data aggregation.

III. Prenatal Imaging Modalities and Their Diagnostic Performance

  1. Ultrasound (US) and Neurosonography

Ultrasound is the primary imaging modality for evaluating fetal CNS anatomy. Key indirect markers of ACC include:

  • Absent cavum septi pellucidi (CSP)
  • Parallel lateral ventricles
  • Colpocephaly
  • Teardrop-shaped ventricles
  • Elevated third ventricle

Neurosonography, a multiplanar approach with targeted CNS evaluation, improves diagnostic sensitivity.

Key metrics from Zhang (2023):

  • Overall sensitivity of prenatal US for ACC: 72%
  • Specificity: 98%
  • Sensitivity for neurosonography: 84%
  • Sensitivity for routine screening: 57%

Conclusion: Neurosonography significantly increases diagnostic yield. However, first-trimester scans (Ungureanu et al.) are limited in detecting CC anomalies due to incomplete anatomical development before 20 weeks.

  1. Fetal Magnetic Resonance Imaging (MRI)

MRI offers superior soft tissue contrast and is especially valuable when US findings are equivocal. According to D’Antonio et al. (2021), MRI revealed additional CNS anomalies in 11.2% of fetuses with “isolated” CC anomalies diagnosed by ultrasound, mainly malformations of cortical development. Even so, 3.9% of anomalies were missed by both modalities and diagnosed postnatally.

MRI is thus a critical adjunct in prenatal CC assessment, particularly in cases of suspected pACC, cortical abnormalities, or abnormal neurodevelopmental prognosis.

  1. Corpus Callosum Biometry and Measurement Challenges

Measuring the length and thickness of the CC provides quantitative assessment but remains controversial. As discussed by D’Antonio et al. (2024):

  • Biometric reference charts for CC are highly variable
  • Quantile regression modeling normalized to head circumference provides improved centile estimation
  • A “short CC” may reflect a normal variant or an early sign of neurodevelopmental disorder

Tutschek et al. (2020) documented short CC in fetuses with Down syndrome and normal brain morphology, suggesting it may serve as an early soft marker for genetic syndromes.

Currently, there is no consensus on routine measurement or the threshold for clinical concern in isolated short CC findings.

  1. Genetic Investigations in CC Anomalies

The genetic basis of CC anomalies is increasingly recognized. According to Mustafa et al. (2024):

  • 43% of ACC cases had pathogenic or likely pathogenic variants on exome sequencing (ES) following normal chromosomal microarray (CMA)
  • Diagnostic yield was highest in:
    • ACC with extracranial anomalies: 55%
    • ACC with other CNS anomalies: 43%
    • Isolated ACC: 32%

Variants were distributed across 83 genes, with recurrent mutations in TUBA1A, L1CAM, FGFR2, ARID1B, and ZEB2, among others.

These findings support the routine integration of ES into the diagnostic pathway for fetal ACC, particularly in cases where standard karyotyping and CMA are normal.

  1. Prognosis and Postnatal Outcomes
  2. Isolated vs Non-Isolated Anomalies

Numerous studies, including Huang et al. (2024) and Di Pasquo et al. (2022), emphasize the prognostic importance of distinguishing isolated CC anomalies from non-isolated cases (those with other CNS or extracranial findings):

  • Isolated ACC or DCC:
    • 65–90% have normal neurodevelopment
    • Good visual, motor, and cognitive outcomes possible
  • Non-isolated cases:
    • Higher risk of neurological disability
    • Greater likelihood of genetic disorders
    • Increased rates of termination of pregnancy

In Huang’s study, 86% of children with isolated dysplastic CC had normal development, compared to 17% in the non-isolated group.

  1. Morphological Subtypes and Prognosis

Huang et al. also compared outcomes by CC morphology:

  • Thin CC: 71% good outcome
  • Short CC: 0% good outcome
  • Thick CC: 0% good outcome

This suggests that “thin but complete” CC may be a benign variant, while short or thick CC may be associated with more severe developmental consequences.

  1. Septo-Optic Dysplasia (SOD)

Di Pasquo et al. showed that 19% of fetuses with isolated absence of the septum pellucidum were diagnosed postnatally with SOD, including 9% of those with apparently normal optic pathways on imaging. This underscores the need for cautious counseling even in “isolated” midline defects.

VII. Counseling, Follow-Up, and Management

Effective counseling must address the uncertainty of neurodevelopmental outcomes, even in isolated cases. Wu & Chen (2024) emphasize:

  • Importance of a multidisciplinary team (fetal medicine, genetics, neurology)
  • Use of MRI and genetic testing to stratify risk
  • Discussion of potential for:
    • Intellectual disability
    • Motor or language delays
    • Behavioral and psychiatric comorbidities (e.g., ADHD, autism)

Where available, postnatal follow-up with neurodevelopmental assessments (e.g., ASQ-3) should be recommended.

In addition, serial prenatal imaging is advised, as shown by Ungureanu et al., since some anomalies may not be detectable until the second or third trimester.

VIII. Conclusion and Future Directions

The prenatal diagnosis of corpus callosum anomalies is a rapidly evolving field. Key conclusions include:

  • Neurosonography and MRI are complementary, with MRI essential in ambiguous or high-risk cases.
  • Terminological clarity and classification standardization are urgently needed.
  • Biometric evaluation (especially CC length) should be interpreted cautiously and ideally normalized to head size.
  • Exome sequencing offers substantial added value, especially after negative CMA.
  • Isolated CC anomalies are often associated with favorable outcomes, but exceptions exist, particularly in cases of septal agenesis or subtle cortical malformations.
  • Genetic counseling, comprehensive imaging, and structured follow-up are crucial for optimal management and support.

As imaging resolution, genetic diagnostics, and outcome databases continue to improve, future approaches will likely shift toward precision prognostication and individualized counseling based on combined imaging-genetic-risk models.

Bibliographie

Introduction and General Context

This article is a correspondence piece in Ultrasound in Obstetrics & Gynecology, which addresses the topic of corpus callosum (CC) biometry in the fetus and its implications for prenatal counseling. The authors begin by recalling the increasing role of corpus callosum assessment in fetal neurosonography. They note that while complete agenesis of the CC can often be identified using indirect sonographic signs, subtler forms of CC anomalies—such as partial agenesis or hypoplasia—require more precise morphometric evaluation.

The central theme of the article is the variability in corpus callosum length and the uncertainty surrounding its clinical interpretation when measurements are “too short” or “too long” relative to gestational age or head size. The authors emphasize the need for accurate biometric reference charts for CC length and highlight the challenges in distinguishing physiological variants from early manifestations of abnormal neurodevelopment.

Anatomical and Clinical Importance of the Corpus Callosum

The corpus callosum is described as a major commissural structure in the fetal brain, crucial for interhemispheric communication. The article underscores its clinical importance in several fetal conditions, such as:

  • Ventriculomegaly
  • Fetal growth restriction (FGR)
  • Congenital heart disease

In these contexts, deviations in CC length may be linked to increased risk of neurodevelopmental impairment, though the exact prognostic significance remains variable.

The authors explain that the CC’s dimensions vary significantly between individuals, across ethnic groups, and with gestational age. A short CC may reflect a normal physiological variant or may be an early indicator of a more significant developmental abnormality.

Overview of the Current Literature and Reference Charts

The article references a recent systematic review (Corroenne et al., 2023), which analyzed methodologies for constructing fetal CC biometric charts. The authors summarize that many existing studies:

  • Were retrospective
  • Did not use blinded assessments
  • Relied on heterogeneous postnatal confirmation methods
  • Did not employ longitudinal designs

They also mention other systematic reviews that assessed the methodological quality of brain charts based on ultrasound and MRI. These reviews similarly highlighted limitations in existing references for fetal brain biometry, including the corpus callosum.

Presentation of the Authors’ Own Study

The authors describe a cross-sectional study conducted on 344 low-risk singleton pregnancies between 19 and 34 weeks of gestation. All pregnancies were accurately dated in the first trimester.

Corpus Callosum Measurement:

  • The CC length was measured in the midsagittal plane.
  • The authors used quantile regression to generate centile curves for CC length.
  • Measurements were analyzed:
    • As a function of gestational age
    • As a function of head circumference

This approach allowed for the generation of percentile charts that reflect the natural distribution of CC measurements in the study population.

Advantages of Quantile Regression in CC Charting

The article explains the rationale for using quantile regression to model fetal CC length:

  • It accounts for the non-normal distribution of brain biometric data.
  • It enables direct estimation of centiles (e.g., 5th, 50th, 95th).
  • It reduces sensitivity to outliers compared to mean-based models.
  • It facilitates more precise estimation of values at the extremes of the distribution.

The authors also highlight the decision to normalize CC length by head circumference rather than gestational age alone. This adjustment is considered particularly important in scenarios where the fetal head may be under- or overgrown (e.g., in FGR or macrosomia), allowing for more appropriate assessment of CC development in these contexts.

They provide two visual plots:

  • One showing CC length by gestational age
  • Another showing CC length by head circumference
    These are accompanied by predicted centiles and ranges (data available in online supplementary tables).

Role of the International Guidelines

The article notes that current ISUOG guidelines on fetal neurosonography do not specify whether CC length should be measured routinely. They also do not indicate how to interpret the finding of a short but morphologically normal CC.

As a result, when a short CC is identified in isolation, clinicians face uncertainty in prognostication and in deciding whether further testing or follow-up is warranted. This ambiguity can complicate counseling and management planning for expectant parents.

Complementary Role of Fetal MRI

The authors discuss the role of fetal MRI as an adjunct to ultrasound in cases of suspected CC anomalies. They explain, however, that fetal MRI also suffers from:

  • High interobserver variability in CC measurements
  • Greater heterogeneity in reference charts
  • Limited number of normative studies
  • Risk of selection bias

Therefore, while MRI may help visualize subtle structures more clearly, it does not eliminate the diagnostic uncertainty when CC measurements are borderline.

Summary of the Authors’ Findings and Tools

In summary, the authors:

  • Present new reference charts for fetal CC length based on a large prospective dataset.
  • Apply quantile regression models to enhance centile estimation.
  • Normalize CC length to head circumference, offering a flexible and context-sensitive metric.

They include several supplementary tables in the online version:

  • Table S1: Regression coefficients for CC length vs. gestational age
  • Table S2: Regression coefficients for CC length vs. head circumference
  • Table S3: Predicted CC lengths by gestational age
  • Table S4: Predicted CC lengths by head circumference

Conclusion and Clinical Implications

The authors conclude that:

  • Quantile-based CC length charts offer an improved method for evaluating the fetal CC in neurosonography.
  • These charts may support clinicians in estimating fetal prognosis, particularly in cases of growth restriction or other high-risk conditions.
  • However, due to limitations in their current dataset (non-longitudinal design, relatively small cohort), their reference curves should be applied with caution.

They emphasize that further longitudinal studies with outcome data are needed to validate the predictive value of CC length centiles. In the interim, specialists should remain prudent when interpreting isolated findings of short CC length and should integrate these findings with the broader clinical picture.

Introduction and General Context

This article reports on a clinical observation linking a shortened fetal corpus callosum (CC) with trisomy 21 (Down syndrome). The authors note that while neurodevelopmental delay and intellectual disability are hallmark features of Down syndrome, overt structural anomalies of the brain—particularly in the prenatal period—are generally rare. The study seeks to explore whether a short CC might constitute a subtle, yet detectable, brain feature associated with trisomy 21 in fetuses that otherwise appear structurally normal.

The motivation for this investigation arises from postnatal neuroimaging and autopsy studies that have described CC anomalies and reduced CC volume in individuals with Down syndrome. Despite this, fetal imaging studies had not previously characterized CC length in fetuses diagnosed with trisomy 21. The authors thus aimed to describe CC length in a small sample of fetuses with trisomy 21, observed through routine prenatal neurosonographic assessment.

Background on Corpus Callosum in Down Syndrome

The article references earlier studies in postnatal populations that showed:

  • Corpus callosum hypoplasia and atrophy in adults with Down syndrome.
  • Structural alterations in the CC identified via MRI.
  • Reports of partial agenesis in rare twin cases with trisomy 21.

These findings raise the question of whether the CC may already be affected during fetal development, even in the absence of overt malformations or additional CNS anomalies.

Study Design and Protocol

  1. Case Identification

The article reports on the first four fetuses with confirmed trisomy 21 in whom the corpus callosum length (CCL) was measured in a routine clinical setting following the introduction of a new institutional neurosonographic protocol. All four fetuses:

  • Had confirmed trisomy 21, either by invasive testing or non-invasive prenatal testing.
  • Showed no other structural brain anomalies at the time of assessment.
  • Were evaluated in the second and third trimesters, at different gestational ages ranging from 20 to 36 weeks.
  1. Measurement Protocol
  • CCL was measured using B-mode transabdominal ultrasound.
  • The midsagittal view of the fetal brain was used to obtain the longest visible segment of the CC.
  • Electronic calipers were employed to measure the corpus callosum.
  • The measurements were performed by a single operator, and then verified by a second observer for accuracy.
  1. Reference Data

The CC measurements in the study were compared against a reference chart developed by Cignini et al. (2014), which includes CC length data for 2950 normal fetuses. The authors selected this reference because:

  • It was based on a large sample size.
  • It employed recent measurement techniques.
  • The 5th centile in this chart was lower than that reported in many earlier charts, making it a conservative comparison.

Results

  1. Corpus Callosum Length in the Four Fetuses
  • Three of the four fetuses had CC lengths below the 5th centile for gestational age.
  • Two fetuses had longitudinal follow-up, with CC measurements taken at two or more gestational timepoints:
    • In both cases, the CC length increased over time.
    • However, the values remained consistently below the 5th centile.
  1. Visualization
  • The midsagittal plane allowed clear visualization of the CC in all cases.
  • No evidence of partial agenesis, dysgenesis, or gross malformation was observed.
  • The CC appeared morphologically normal but measurably short.
  1. Graphical Representation
  • The article includes a scatterplot (Figure 1) showing individual CC length measurements from the four fetuses.
  • The plot is overlaid with the 5th, 50th, and 95th centiles from the Cignini reference chart, allowing visual comparison across gestational age.

Sonographic Technique and Reproducibility

The authors emphasize that:

  • CCL measurement is feasible with routine transabdominal ultrasound, provided that the midsagittal plane is adequately visualized.
  • The technique has demonstrated good reproducibility:
    • A prior study cited by the authors showed an intra- and interobserver correlation coefficient of 0.95 for CCL measurements between 23–28 weeks of gestation.

Discussion of Soft Markers and Diagnostic Implications

The article situates its findings within the broader context of soft markers for Down syndrome. Over the last decades, numerous sonographic markers have been described, such as:

  • Nuchal translucency
  • Absent nasal bone
  • Echogenic bowel
  • Mild ventriculomegaly

However, brain anomalies are not usually considered a hallmark of trisomy 21. The findings of this study suggest that a short but morphologically normal corpus callosum may be a previously under-recognized feature in some cases.

All four fetuses in the study had abnormal first-trimester nuchal translucency measurements, and most had undergone non-invasive prenatal testing (NIPT) or invasive karyotyping prior to the sonographic assessment.

The authors propose that CC length may become an additional parameter worth observing in fetuses with confirmed or suspected trisomy 21, especially when the brain appears structurally normal in other respects.

Future Directions

Although the current study includes only four cases, the authors note that:

  • A larger-scale study has already been initiated to systematically assess CC length in a broader population of fetuses with trisomy 21.
  • The goal is to define normal and abnormal ranges in this specific subgroup and assess whether CCL could be used as a prenatal marker for trisomy 21 or neurodevelopmental prognosis.

They emphasize that the clinical implications of a short CCL in fetuses with trisomy 21 remain to be determined. However, the consistent finding of shortened CC in this small sample suggests a possible link with underlying developmental patterns that merit further investigation.

Conclusion

The article concludes that:

  • In this small observational cohort, a short corpus callosum was observed in most fetuses with trisomy 21, despite otherwise normal brain anatomy.
  • This preliminary finding is consistent with postnatal reports of CC abnormalities in individuals with Down syndrome.
  • The study introduces the idea that corpus callosum length may reflect early neurodevelopmental characteristics in this population.
  • These findings provide a rationale for conducting larger, prospective studies to evaluate CC growth and morphology in fetuses with trisomy 21.

Introduction and Context

This article presents a systematic review focused on the definitions, terminology, and classification of fetal corpus callosum (CC) anomalies in the prenatal imaging literature. The authors observe that, while agenesis of the corpus callosum (ACC) has been well described in both prenatal and postnatal literature, there is significant inconsistency in the way partial or atypical anomalies of the CC are defined and labeled in fetal imaging studies.

The aim of the review is to examine and document the heterogeneity of nomenclature and definitions used in studies of fetal CC abnormalities diagnosed via ultrasound or MRI, with the ultimate goal of promoting a more standardized classification system that aligns prenatal terminology with postnatal diagnostic standards.

Objective

The study’s main objectives are:

  1. To systematically review the literature describing fetal CC anomalies identified through prenatal imaging.
  2. To catalog and compare the terms and definitions used for different types of CC anomalies, especially for non-complete agenesis (e.g., partial agenesis, hypoplasia, dysgenesis, etc.).
  3. To assess the consistency and clarity of definitions, and the biometric criteria used across studies.
  4. To advocate for a more unified framework for reporting CC anomalies in the prenatal setting.

Methods

  1. Protocol and Eligibility

The review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.

Inclusion criteria:

  • Prospective or retrospective cohort or case series studies.
  • Reports published in English, French, German, Italian, or Spanish.
  • Prenatal imaging using ultrasound and/or MRI as a core diagnostic tool.
  • Description of anomalies of the corpus callosum in the fetus.

Exclusion criteria:

  • Single case reports.
  • Studies focused solely on biometric norm charting.
  • Reviews, systematic reviews, or meta-analyses.
  • Studies based on neonatal or postnatal imaging.
  1. Search Strategy
  • The literature search was conducted in PubMed up to July 10, 2019.
  • Additional studies were identified by reviewing the references of included articles.
  • A total of 998 records were screened.
  1. Data Extraction and Quality Assessment
  • 24 studies published between 1993 and 2021 were included in the final analysis.
  • Quality and risk of bias were assessed using the Newcastle–Ottawa Scale (NOS) and a modified version of the Conde-Agudelo scale.
  • 15 evaluation criteria were used, covering aspects of study design, reporting, and statistical methodology.

Results

  1. Study Population and Anomaly Types
  • The 24 included studies described 1,135 fetuses with CC anomalies.
  • Of these, 49% had complete agenesis of the corpus callosum (CACC).
  • The remaining 51% were categorized under a wide range of descriptive terms:
    • Partial agenesis of the corpus callosum (PACC) – 22%
    • Short CC – 6%
    • Hypoplastic CC – percentage not specified
    • Thick CC, dysgenesis, hypogenesis, hyperplasia, and other terms – smaller numbers
    • In 18% of cases, the nature of the anomaly could not be precisely determined from the information provided.
  1. Terminological Heterogeneity

The review identified a total of ten different terms used across the studies to describe CC anomalies other than complete agenesis:

  • Partial agenesis (PACC)
  • Hypoplasia
  • Short corpus callosum
  • Dysgenesis
  • Hypogenesis
  • Thick corpus callosum
  • Hyperplasia
  • Dysmorphic corpus callosum
  • Mixed hypo-/hyperplasia
  • Undefined or ambiguous descriptions

Many of these terms were used inconsistently, and several (e.g., PACC, hypoplasia, dysgenesis, short CC) had multiple definitions depending on the study.

Examples of variability:

  • PACC was defined variously as “missing any segment,” “missing the splenium,” or “a short CC despite all components being present.”
  • Hypoplasia was sometimes defined based on CC thickness, other times based on length, or not defined at all.
  1. Diagnostic Modalities
  • Most studies used a combination of neurosonography and fetal MRI.
  • Neurosonography became common in the 1990s, and MRI followed soon after.
  • MRI was primarily used to clarify unclear ultrasound findings or to refine diagnoses (e.g., differentiating partial from complete agenesis).

The added diagnostic yield of MRI was generally modest when expert neurosonography had already been performed.

  1. Postnatal Correlation
  • In most studies, postnatal confirmation was attempted using MRI, CT, ultrasound, or pathology.
  • The overall discrepancy rate between prenatal and postnatal imaging was low, with most errors involving the reclassification of CACC to PACC.

Classification and Definitions

The review highlights that:

  • CACC had a generally consistent definition: absence of all four components of the CC (rostrum, genu, body, and splenium).
  • For PACC, nine distinct definitions were found.
  • For hypoplasia, five different definitions were recorded, based on thickness, length, or subjective appearance.
  • The terminology also did not align well with postnatal literature, which tends to use more structured definitions.

This lack of standardization hinders:

  • Accurate pooling of cases for research
  • Longitudinal outcome studies
  • Genetic association studies
  • Consistent prenatal counseling

Key Tables and Figures

  • Table 1: Newcastle–Ottawa scores across the 24 studies, illustrating variability in study quality.
  • Table 2: Results of the modified Conde-Agudelo quality assessment.
  • Figure 1: PRISMA flow diagram showing the study selection process.
  • Table 3: Comparison of terminology and definitions used in included studies.
  • Table S3 (supplementary): Detailed descriptions of the CC anomalies reported per study.

Summary and Recommendations

The authors conclude that:

  • There is marked heterogeneity in how fetal CC anomalies are defined and described in the prenatal imaging literature.
  • Terms such as PACC, hypoplasia, and dysgenesis are used inconsistently and with overlapping meanings.
  • This variability prevents meaningful aggregation of data across studies, complicates prognostication, and hampers efforts to understand the genetic and developmental basis of CC anomalies.
  • A simplified and standardized classification system, consistent with postnatal definitions, is urgently needed.

Such a system would:

  • Improve diagnostic consistency across imaging centers
  • Facilitate the formation of large, well-phenotyped multicenter cohorts
  • Enable better correlation with neurodevelopmental outcomes
  • Guide clinical management and parental counseling more effectively

Introduction and Clinical Context

This article presents a large multicenter retrospective cohort study designed to evaluate the role of prenatal magnetic resonance imaging (MRI) in fetuses diagnosed with an apparently isolated anomaly of the corpus callosum (CC) based on neurosonographic assessment. The CC is one of the most commonly affected structures in fetal central nervous system (CNS) malformations, and its anomalies—particularly agenesis—can occur in isolation or in association with other cerebral or extracerebral defects.

The authors note that, although prenatal ultrasound is the primary tool for detecting CC anomalies, MRI is often employed as a second-line modality to detect subtle or additional abnormalities that may influence prognosis. However, the added diagnostic value of MRI when expert neurosonography has already been performed remains uncertain. This study aims to quantify that added value.

Study Design and Methodology

  1. Type of Study
  • Retrospective multicenter cohort study
  • Conducted across 14 fetal medicine centers in Europe and North America (Italy, United Kingdom, Spain, Portugal, Austria, and Canada)
  1. Inclusion Criteria
  • Fetuses with a prenatal diagnosis of isolated CC anomaly (complete or partial agenesis) based on expert multiplanar neurosonography
  • Normal fetal karyotype and chromosomal microarray
  • Maternal age ≥ 18 years
  • Gestational age at diagnosis ≥ 18 weeks
  • MRI performed within 2 weeks of the neurosonographic diagnosis
  1. Exclusion Criteria
  • Associated CNS or extra-CNS anomalies
  • Concomitant severe ventriculomegaly (≥15 mm)
  • Abnormal genetic findings or congenital infections
  • Inadequate or unconfirmed imaging diagnosis
  1. Objectives
  • Primary objective: To assess the rate of additional CNS anomalies identified exclusively on fetal MRI following an apparently isolated CC anomaly diagnosis by neurosonography.
  • Secondary objectives:
    • To determine the rate of additional anomalies by type of CC anomaly (complete vs. partial agenesis)
    • To identify cases where anomalies were detected only postnatally, having been missed by both ultrasound and MRI

Results

  1. Study Population
  • Total of 269 fetuses included:
    • 207 with complete agenesis of the corpus callosum (cACC)
    • 62 with partial agenesis (pACC)
  • MRI performed within 1 week of neurosonography in 81.8% of cases
  • Outcomes available for 259 fetuses (96.3%):
    • 116 live births
    • 143 terminations of pregnancy (TOP)
    • 10 lost to follow-up
  1. Primary Outcome
  • MRI identified additional CNS anomalies in 11.2% (30/269) of fetuses
    • These anomalies had not been detected on neurosonography
    • Most common: Malformations of cortical development (25/30 cases)
    • Other anomalies:
      • Posterior fossa anomalies (1 case)
      • Hemorrhagic or hypoxic lesions (1 case)
      • Complex intracranial anomalies (3 cases)
  1. By Type of CC Anomaly
  • Additional anomalies on MRI:
    • cACC: 24/207 cases (11.6%)
    • pACC: 6/62 cases (9.7%)
  • Malformations of cortical development were the most common in both subgroups:
    • 10.6% in cACC
    • 4.8% in pACC
  1. Postnatal Findings
  • In fetuses with isolated CC anomalies and no anomaly detected on either neurosonography or MRI, 3.9% (8/205) were found postnatally to have structural CNS anomalies:
    • 2 posterior fossa anomalies
    • 6 cortical development anomalies
  1. Factors Associated with Diagnostic Yield
  • Maternal body mass index (BMI) was the only independent factor associated with an increased likelihood of detecting anomalies on MRI:
    • Higher BMI → Higher risk of anomalies identified on MRI
    • Odds ratio: 1.07 (95% CI: 1.01–1.14)
  • No significant correlation found between anomaly detection and:
    • Gestational age
    • Interval between ultrasound and MRI
    • Type of CC anomaly (complete vs. partial)

Imaging Protocols

  1. Neurosonography
  • Performed using ISUOG-recommended protocol
  • Axial, sagittal, and coronal planes of the fetal brain
  • Transvaginal approach used when fetal position allowed
  1. Fetal MRI
  • Conducted using 1.5-T MRI systems
  • T2-weighted images in three orthogonal planes (axial, sagittal, coronal)
  • T1 and echoplanar sequences added when necessary

MRI was used to identify abnormalities such as:

  • Abnormal gyration
  • Polymicrogyria
  • Lissencephaly
  • Posterior fossa abnormalities

Discussion of Outcomes

  • MRI had a limited but relevant added value, identifying CNS anomalies in 11.2% of cases not previously diagnosed via ultrasound.
  • Even after both imaging modalities, a small percentage of CNS anomalies were diagnosed only postnatally, underscoring the limitations of prenatal imaging.
  • The anomalies detected solely by MRI (especially cortical development anomalies) are significant in terms of prognosis, affecting long-term neurodevelopment.

Summary Tables and Figures

  • Table 1: Maternal and fetal characteristics (maternal age, BMI, GA, timing of imaging, anomaly type)
  • Table 2: Distribution of additional CNS anomalies detected by MRI and postnatally
  • Table 3: Comparative analysis of fetuses with vs. without additional anomalies (by maternal/fetal variables)
  • Table 4: Multivariate logistic regression analysis of factors influencing anomaly detection

Conclusion

The authors conclude that:

  • In fetuses diagnosed with apparently isolated ACC via expert neurosonography, fetal MRI reveals additional CNS anomalies in ~11% of cases, predominantly malformations of cortical development.
  • These findings support the integrated use of MRI to refine prognostic information and improve prenatal counseling.
  • Despite comprehensive imaging, 3.9% of fetuses were found to have additional anomalies only after birth, emphasizing that prenatal imaging cannot entirely eliminate diagnostic uncertainty.
  • Maternal BMI is an independent predictor of additional findings on MRI and should be considered when determining the need for additional imaging.

The study affirms that MRI should be offered in cases of isolated CC anomalies to increase diagnostic precision, although even combined imaging strategies are not infallible.

Introduction and Background

This article presents the results of a retrospective cohort study combined with a systematic review and meta-analysis, focusing on the prenatal diagnosis of isolated agenesis of the septum pellucidum (ASP) and the associated postnatal outcomes, including the risk of septo-optic dysplasia (SOD).

The septum pellucidum (SP) is a thin midline brain structure located between the lateral ventricles. Isolated absence of the SP may be benign, but it can also be a sign of serious conditions like SOD, which is associated with optic nerve hypoplasia and pituitary dysfunction. Diagnosing ASP accurately during pregnancy is challenging, especially in distinguishing isolated ASP from more complex cerebral anomalies.

The aim of this work is to evaluate:

  1. The rate of neurological disability in children prenatally diagnosed with isolated ASP.
  2. The frequency of SOD, including in fetuses with normal optic pathways on prenatal imaging.

Study Design and Methods

  1. Study Components

The article is composed of:

  • A retrospective cohort study conducted in two European tertiary care centers.
  • A systematic review and meta-analysis including all published studies meeting inclusion criteria.
  1. Retrospective Cohort Study
  • Study period: 2010–2020
  • Centers: University Hospital of Parma (Italy) and Hôpital Necker-Enfants Malades (Paris, France)
  • Included cases: 15 fetuses with apparently isolated ASP diagnosed by ultrasound and/or fetal MRI.

Inclusion criteria:

  • Isolated agenesis of the SP (partial or complete)
  • No other major CNS or extracranial anomalies
  • Available postnatal follow-up data

Exclusion criteria:

  • Severe ventriculomegaly (atrial width ≥ 15 mm)
  • Associated major brain anomalies
  • Incomplete follow-up
  1. Systematic Review and Meta-Analysis
  • Databases searched: Medline and EMBASE (April 2020, updated February 2021)
  • Search terms included: agenesis of septum pellucidum, septo-optic dysplasia, prenatal diagnosis, outcome
  • Eligibility: Cohort studies with ≥3 patients, prenatal diagnosis of isolated ASP, and postnatal follow-up data.

Number of studies included: 6
Total cases analyzed (cohort + literature): 78 fetuses

Results

  1. Retrospective Cohort Results
  • 15 fetuses included:
    • 4 with complete ASP
    • 11 with partial ASP
  • All underwent detailed neurosonography and fetal MRI.
  • Optic pathways (optic nerves, tracts, chiasm) appeared normal in all but one fetus on prenatal imaging.
  • One fetus showed prenatal hypoplasia of the optic tracts and chiasm → confirmed postnatal SOD.
  • Genetic testing (karyotype and/or chromosomal microarray) performed in 10/15 cases; all were normal.
  • Median follow-up duration: 36 months (range 12–60 months)

Postnatal outcomes:

  • 14/15 children had normal neurological, endocrinological, and visual development.
  • 1 case diagnosed postnatally with SOD and visual impairment.
  1. Meta-Analysis Results (78 total cases)
  • Genetic anomalies: 2/30 cases had abnormal results
    → Pooled proportion: 9.0% (95% CI: 1.8–20.7%)
  • Additional or discordant findings on postnatal imaging:
    9/70 cases → Pooled proportion: 13.7% (95% CI: 3.5–29.0%)
  • Septo-optic dysplasia (SOD) diagnosed postnatally:
    14/78 cases → Pooled proportion: 19.4% (95% CI: 8.6–33.2%)
  • Among 60 fetuses with normal optic pathways on prenatal imaging:
    • 6 cases developed SOD postnatally
    • Pooled proportion: 9.1% (95% CI: 1.1–24.0%)
  • Among non-SOD children (n = 46) with follow-up data:
    • 3 had major neurological disability (motor, language, or behavioral disorders, or epilepsy)
    • Pooled proportion: 6.5% (95% CI: 0.5–18.6%)

Imaging and Diagnostic Protocols

  1. Prenatal Imaging
  • Neurosonography and fetal MRI performed in all cohort cases
  • Prenatal MRI provided clear delineation of SP absence and optic pathway assessment
  • Particular focus was placed on the optic nerves, optic tracts, and optic chiasm
  1. Postnatal Follow-Up
  • Included:
    • Neurological evaluation
    • Endocrinological and ophthalmological assessments
    • Imaging (MRI or ultrasound)
  • Follow-up duration ranged from 12 to 60 months

Definitions and Classifications Used

  • ASP was considered complete when both leaflets of the septum pellucidum were absent
  • Partial ASP: absence of only one leaflet
  • SOD diagnosis required presence of:
    • ASP
    • Optic nerve hypoplasia and/or
    • Pituitary hormone deficiency (diagnosed postnatally)
  • Major neurological disability defined as:
    • Motor deficit
    • Language delay
    • Behavioral disorder
    • Epilepsy

Figures and Tables

  • Figure 1: MRI and ultrasound images showing complete ASP in coronal section
  • Figure 2: PRISMA flowchart for the literature selection
  • Table 1: Characteristics of the 15 cohort cases (gestational age at diagnosis, imaging findings, outcomes)
  • Table 2: Description and characteristics of included studies from the systematic review
  • Table 3: Quality assessment of included studies
  • Table 4: Meta-analytic data for key outcome parameters (genetics, SOD, postnatal discrepancies, disabilities)

Conclusion

The authors conclude that:

  • In most cases of apparently isolated ASP, the long-term prognosis is favorable.
  • However, a significant proportion (13–14%) may have additional anomalies identified postnatally, despite normal prenatal ultrasound and MRI.
  • Septo-optic dysplasia (SOD) occurs in approximately 20% of cases; importantly, optic pathway anomalies may not be detectable prenatally, even on MRI.
  • A detailed antenatal evaluation of the optic pathways (via ultrasound and MRI) is strongly recommended.
  • Clinicians should be cautious in offering reassuring counseling solely based on normal prenatal imaging, due to the risk of undetected SOD.
  • Postnatal follow-up is essential to detect delayed manifestations of SOD or other neurological impairments.

Introduction and Background

This article presents a systematic review and meta-analysis assessing the diagnostic yield of exome sequencing (ES) following negative chromosomal microarray analysis (CMA) in pregnancies with a prenatal diagnosis of agenesis of the corpus callosum (ACC). ACC is a common congenital anomaly of the central nervous system that can be complete or partial and may occur in isolation or in association with other anomalies.

Given the genetic heterogeneity of ACC, standard karyotyping and CMA may fail to detect many underlying monogenic disorders. Exome sequencing has emerged as a powerful tool for uncovering pathogenic variants in such cases, but its use in the prenatal setting, particularly for ACC, is not yet standardized. This study aims to provide a quantitative synthesis of the diagnostic yield of ES in this specific context.

Methods

  1. Literature Search and Selection
  • Databases searched: PubMed, SCOPUS, Web of Science, and Cochrane Library
  • Time frame: From inception to June 2022
  • Search strategy followed PRISMA guidelines
  • Studies were eligible if they:
    • Reported prenatal ACC diagnoses
    • Included negative CMA/karyotyping
    • Used exome sequencing in the prenatal or perinatal period
    • Reported outcomes using ACMG classification
  1. Study Inclusion
  • 28 studies included in the systematic review
  • 15 studies included in the meta-analysis (≥3 ACC cases each)
  • Total of 288 cases analyzed for the systematic review
  • 268 cases included in the meta-analysis
  1. Data Extracted
  • Number of ACC cases with pathogenic or likely pathogenic (P/LP) variants
  • Classification of ACC: isolated, with other cranial anomalies, or with extracranial anomalies
  • Type of ES (trio, proband-only)
  • Genes and variants identified

Results

  1. Overall Diagnostic Yield
  • 43% of all included ACC cases (115/268) had P/LP variants detected by ES
  • Diagnostic yield varied by ACC type:
    • ACC with extracranial anomalies: 55% (95% CI: 35–73%)
    • ACC with other cranial anomalies: 43% (95% CI: 30–57%)
    • Isolated ACC: 32% (95% CI: 18–51%)
  1. Gene Discovery
  • A total of 116 pathogenic/likely pathogenic variants were classified
  • These variants were found in 83 different genes
  • Most frequently implicated genes:
    • TUBA1A (7 cases)
    • L1CAM (6 cases)
    • FGFR2 (5 cases)
    • ARID1B, ARX, COL4A1, EPG5, PEX1, TUBB, ZEB2 (3 cases each)
  1. ACC Phenotype by Genetic Subtype
  2. Isolated ACC (25 cases):
  • 19 genes identified
  • Most common:
    • ARID1B, L1CAM (3 cases each)
    • EPG5, NFIA (2 cases each)
  • Inheritance:
    • Autosomal dominant: 70.8% (17/24), mostly de novo
    • Autosomal recessive: 16.7%
    • X-linked: 12.5%
  1. ACC with other cranial anomalies (41 cases):
  • 30 genes
  • Most common:
    • TUBA1A (6 cases), COL4A1, TUBB (3 each)
  • Inheritance:
    • Autosomal dominant: 55.3%
    • Autosomal recessive: 15.8%
    • X-linked: 28.9%
  1. ACC with extracranial anomalies (44 cases):
  • 40 genes
  • Most common:
    • FGFR2 (5 cases), ZEB2 (2 cases)
  • Inheritance:
    • Autosomal dominant: 63.2%
    • Autosomal recessive and X-linked: also present but in lower proportions
  1. Variant Classification
  • Reanalysis was conducted using ACMG guidelines and supported by:
    • Alamut Visual
    • ClinVar
    • DECIPHER
    • gnomAD
  • Variants were harmonized to a five-tier system: pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign, benign
  • Majority of positive findings were de novo mutations in autosomal dominant genes

Additional Findings

  1. Pregnancy Outcomes
  • Among 84 cases with a P/LP variant and reported outcomes:
    • 69 (82.1%) underwent termination of pregnancy
    • 2 stillbirths
    • 3 neonatal deaths
    • 10 live births
  1. Type of Exome Sequencing
  • In 113 cases with known ES methodology:
    • Trio testing performed in 95.6%
    • Proband-only or duo testing in a few cases
  1. Clinical Syndromes Identified
  • Several well-known genetic syndromes were confirmed:
    • Apert syndrome, Mowat–Wilson syndrome, Coffin–Siris syndrome
    • X-linked hydrocephalus, tubulinopathies, oral-facial-digital syndrome

Tables and Figures

  • Figure 1: PRISMA flow diagram
  • Table 1: Summary of affected genes and associated phenotypes
  • Figure 2: Forest plot showing diagnostic yield by ACC type
  • Tables S1–S4 (Supplementary): Detailed variant information, gene frequencies, and phenotype correlations

Study Quality Assessment

  • Most studies used:
    • Trio sequencing
    • Sanger validation
    • ACMG classification
  • Quality assessed using modified STARD criteria
  • Diagnostic accuracy considered high where these criteria were fulfilled

Conclusions

The authors conclude that:

  • Exome sequencing provides significant additional diagnostic yield in fetuses with ACC, especially after negative CMA results.
  • Monogenic disorders are common in both isolated and non-isolated ACC.
  • The highest yield is observed in cases where ACC is associated with extracranial anomalies, but even isolated cases benefit from ES (yield ~32%).
  • Genetic testing should be systematically considered in the diagnostic workup of prenatal ACC.
  • Identification of a molecular diagnosis informs:
    • Prenatal counseling
    • Prognostication
    • Family planning
    • Eligibility for gene-specific therapies or surveillance in postnatal life

The study supports the integration of prenatal ES into clinical practice for structural brain anomalies, particularly when standard cytogenetics and microarrays are unrevealing.

Introduction and Background

This article presents a retrospective cohort study conducted in China, aimed at analyzing the long-term outcomes and genetic characteristics of fetuses diagnosed prenatally with dysplasia of the corpus callosum (DCC) or partial agenesis of the corpus callosum (PACC).

The corpus callosum (CC), the largest commissural structure in the fetal brain, plays a critical role in interhemispheric communication. CC anomalies are common findings in fetal neurosonography and may range from isolated anomalies with good outcomes to complex malformations associated with neurodevelopmental delays. The study categorizes CC abnormalities into distinct morphotypes—short, thin, and thick CCs—and compares outcomes based on whether the malformation was isolated or associated with other anomalies.

Methods

  1. Study Setting and Population
  • Location: Peking University First Hospital, China
  • Study period: January 2016 to December 2022
  • Design: Retrospective analysis
  • Cases included: 42 fetuses diagnosed with:
    • Dysplasia of the corpus callosum (DCC): 36 cases
    • Partial agenesis of the corpus callosum (PACC): 6 cases
  1. Inclusion Criteria
  • Gestational age ≥ 20 weeks at diagnosis
  • Sufficient quality neurosonographic imaging available
  • Clear diagnosis of DCC or PACC based on neurosonography and/or MRI
  1. Exclusion Criteria
  • Poor quality imaging
  • Absence of detailed fetal brain assessment
  • Unavailable follow-up
  1. Imaging Protocol
  • Ultrasound performed with Voluson E8/E10 systems
  • Transabdominal and transvaginal neurosonography used
  • ISUOG guidelines applied for CNS and CC evaluation
  1. Morphological Classification of DCC
  • Short CC: Anteroposterior length below 3rd percentile
  • Thin CC: Subjectively narrow appearance, normal length
  • Thick CC: Abnormally enlarged appearance compared to normative datasets
  1. Genetic Testing
  • CMA (chromosomal microarray analysis) performed in 21 cases
  • Whole exome sequencing (WES) performed in 18 cases (combined CMA + WES)
  • Trio-based testing when permitted by parents
  1. Follow-Up
  • Postnatal development assessed using the ASQ-3 (Ages and Stages Questionnaire, 3rd Edition)
  • Duration of follow-up: 12–60 months
  • Evaluated domains: gross motor, fine motor, language, behavior

Results

  1. Grouping
  • Isolated group: 15 fetuses (35.7%)
  • Non-isolated group: 27 fetuses (64.3%)
    • Associated CNS anomalies: ventriculomegaly, schizencephaly, interhemispheric cysts, malformations of cortical development, etc.
    • Associated extracranial anomalies: congenital heart defects, limb deformities, micrognathia
  1. Pregnancy Outcomes
  • Isolated group:
    • 8 terminations
    • 7 live births
    • Of 7 live-born:
      • 6 normal development
      • 1 gross motor delay at 12 months
  • Non-isolated group:
    • 21 terminations
    • 6 live births
    • Of 6 live-born:
      • 4 with neurological deficits (language, motor, intellectual delay, or epilepsy)
      • 1 death 10 days postpartum
      • 1 child with normal development

Statistical significance:

  • Favorable outcome in 86% of isolated group (6/7) vs 17% in non-isolated group (1/6)
  • χ² = 6.198, P = 0.01279
  1. Genetic Results
  • Pathogenic or likely pathogenic (P/LP) variants:
    • Isolated group: 2/13 cases (15.4%)
    • Non-isolated group: 12/26 cases (46.2%)
  • Variants detected included:
    • ARID1B, associated with autism spectrum disorder
    • PTEN, associated with macrocephaly and developmental delay
    • Trisomy 18 and other de novo gene alterations

No significant difference in P/LP rate between groups (χ² = 3.566, P = 0.05897), but clear trend toward more variants in non-isolated group.

  1. DCC Morphology and Prognosis
  • Short CC: 18 cases
    • Live births: 3
    • Good outcomes: 0
    • P/LP variants: 6/17 tested
  • Thin CC: 13 cases
    • Live births: 7
    • Good outcomes: 5 (71.4%)
    • P/LP variants: 3/12 tested
  • Thick CC: 5 cases
    • Live births: 1
    • Good outcome: 0
    • P/LP variants: 2/5 tested

Key Tables and Figures

  • Figure 1: Study flowchart with classification of 42 included cases
  • Figure 2: Ultrasound and MRI images illustrating short, thin, and thick CC morphology
  • Table 1: Demographic and pregnancy characteristics by group
  • Table 2: Summary of outcomes by CC morphology
  • Table 3: Genetic results by morphotype and group
  • Table 4: Developmental follow-up results

Discussion Points (Descriptively Reported)

  • CC morphotype significantly influences prognosis: thin CC associated with better outcomes than short or thick variants.
  • Isolated CC dysplasia is more likely to result in normal postnatal development.
  • Presence of additional brain or systemic malformations correlates with poorer prognosis and higher rate of genetic anomalies.
  • Some cases with normal prenatal imaging may still present with subtle postnatal developmental delay, reinforcing the need for follow-up.
  • Genetic testing (especially WES) was valuable in identifying underlying etiologies even in isolated cases.

Conclusion

The authors conclude that:

  • Fetuses with isolated DCC or PACC generally have favorable neurodevelopmental outcomes, particularly when the CC is thin rather than short or thick.
  • The presence of additional CNS or extracranial anomalies significantly increases the risk of poor postnatal prognosis.
  • Genetic testing, especially using combined CMA + WES, is an important component in the evaluation of CC anomalies.
  • Fetuses with thin CCs have the highest likelihood of good neurodevelopment, and this morphology may serve as a positive prognostic indicator.
  • Postnatal follow-up is essential even in apparently normal cases to detect subtle developmental issues.

Introduction and Background

This article presents a meta-analysis evaluating the diagnostic accuracy of prenatal ultrasound in detecting agenesis of the corpus callosum (ACC), using postnatal imaging or postmortem diagnosis as the reference standard.

ACC is a relatively frequent fetal anomaly of the central nervous system (CNS). Its prenatal detection is important for perinatal counseling and prognostication, yet it is often challenging because the diagnosis relies on indirect signs rather than direct visualization of the corpus callosum (CC), especially in routine second-trimester ultrasound screening.

The objective of this meta-analysis is to comprehensively quantify the sensitivity, specificity, and overall diagnostic performance of prenatal ultrasound in identifying ACC.

Methods

  1. Literature Search Strategy
  • Databases searched: PubMed, EMBASE, and Web of Science
  • Search cut-off date: November 1, 2021
  • Search terms: combinations of “prenatal ultrasound,” “ultrasonography,” “sonography,” “corpus callosum,” and “agenesis”
  • Additional manual review of references was performed.
  1. Inclusion Criteria
  • Original articles published in English
  • Evaluation of prenatal ultrasound for diagnosing ACC
  • Reference standard: postmortem findings or postnatal imaging (MRI or CT)
  • Data must allow extraction of 2×2 diagnostic table (true positives, false positives, true negatives, false negatives)
  • Minimum of 3 ACC cases per study
  1. Exclusion Criteria
  • Reviews, case reports, or case series with <3 cases
  • Studies focusing only on general CNS malformations without ACC data
  • Studies using postnatal diagnosis alone without prenatal evaluation
  • Non-English publications
  1. Data Extraction and Quality Assessment
  • Two independent reviewers screened the studies and extracted data
  • QUADAS-2 tool used for evaluating methodological quality
  • Sensitivity, specificity, positive and negative likelihood ratios (PLR, NLR), diagnostic odds ratio (DOR), and area under the receiver operating characteristic curve (AUC) were calculated
  • Heterogeneity assessed using I² statistic
  • Subgroup analysis performed for neurosonography vs routine ultrasound

Results

  1. Studies Included
  • 12 studies published between 2003 and 2021
  • Countries of origin: Austria, Israel, China, United Kingdom, USA, Korea, Poland, Sweden, Turkey, Spain
  • Total fetuses: 544 with suspected CNS anomalies
  • ACC confirmed postnatally in 143 cases
  1. Pooled Diagnostic Performance of Prenatal Ultrasound for ACC
  • Sensitivity: 0.72 (95% CI: 0.39–0.91)
  • Specificity: 0.98 (95% CI: 0.79–1.00)
  • Positive likelihood ratio (PLR): 43.73 (95% CI: 3.42–558.74)
  • Negative likelihood ratio (NLR): 0.29 (95% CI: 0.11–0.74)
  • Diagnostic odds ratio (DOR): 152.02 (high heterogeneity)
  • Area under ROC curve (AUC): 0.94 (95% CI: 0.92–0.96)

These results indicate high overall diagnostic accuracy, especially in terms of specificity.

Subgroup Analysis

  1. Neurosonography vs Routine Screening Ultrasound
  • Neurosonography (7 studies):
    • Sensitivity: 0.84
    • Specificity: 0.98
    • AUC: 0.97
  • Routine screening ultrasound (5 studies):
    • Sensitivity: 0.57
    • Specificity: 0.89
    • AUC: 0.78

This comparison shows that dedicated neurosonography significantly outperforms routine second-trimester screening in detecting ACC.

Figures and Tables

  • Figure 1: PRISMA flowchart of the literature search and study selection process
  • Table 1: Characteristics of included studies (country, gestational age at diagnosis, number of cases, method of confirmation)
  • Table 2: QUADAS-2 assessment results
  • Figure 2A-B: Forest plots of sensitivity and specificity
  • Figure 3: Summary ROC curve showing high AUC
  • Figure 4: Funnel plot for assessing publication bias (symmetrical—low risk of bias)
  • Supplementary figures: Forest plots for subgroup analyses

Sonographic Techniques

  1. Routine Screening
  • Based on second-trimester axial views
  • Diagnosis of ACC suspected based on indirect signs:
    • Absent cavum septi pellucidi
    • Colpocephaly
    • Parallel lateral ventricles
  1. Neurosonography
  • Multiplanar approach using sagittal, coronal, and axial views
  • Direct visualization of CC and pericallosal artery
  • Higher resolution, often including transvaginal sonography

Quality Assessment

  • Most studies showed low risk of bias for patient selection and reference standards
  • Some uncertainty for the “index test” due to incomplete reporting of ultrasound techniques in earlier studies
  • Overall, studies were methodologically adequate to support meta-analysis

Discussion (Descriptive Summary)

  • The high specificity of ultrasound suggests that when ACC is diagnosed prenatally, it is usually confirmed postnatally, indicating low false positive rates.
  • However, sensitivity is moderate, indicating a risk of missed diagnoses, especially with routine ultrasound.
  • Neurosonography significantly improves diagnostic yield.
  • Visualization of the CC requires skill and optimal fetal positioning; hence, standardized neurosonographic training and protocols are essential.
  • Despite high diagnostic accuracy, some ACC cases may still be missed prenatally, underlining the importance of MRI or postnatal evaluation in ambiguous or high-risk cases.

Conclusion

The author concludes that:

  • Prenatal ultrasound is an effective diagnostic tool for detecting agenesis of the corpus callosum, with high specificity and good overall diagnostic performance.
  • Neurosonography, when applied systematically, improves sensitivity and should be implemented when ACC is suspected.
  • Routine screening has limited sensitivity and should not be solely relied upon for excluding CC anomalies.
  • Findings support the integration of targeted neurosonography in second-trimester evaluations when fetal CNS anomalies are suspected.

The study reinforces the need for systematic assessment of the fetal midline and CC, ideally through standardized neurosonographic protocols, to improve prenatal diagnosis and counseling for ACC.

Introduction and Objectives

This article is a narrative review summarizing current knowledge and recommendations on the prenatal diagnosis of anomalies of the corpus callosum (CC) using two-dimensional ultrasound, with a focus on diagnostic criteria, ultrasound markers, and implications for counseling. The CC is a critical structure for interhemispheric brain communication, and its absence or abnormal development may be associated with a broad spectrum of neurological outcomes.

The review aims to:

  • Clarify the sonographic signs that help identify anomalies of the CC
  • Describe the embryological development and normal appearance of the CC
  • Summarize the different categories of CC anomalies
  • Discuss the genetic implications and prognostic outcomes
  • Support clinicians in prenatal counseling

Development and Anatomy of the Corpus Callosum

The corpus callosum is described as a white matter interhemispheric tract responsible for integrating motor, sensory, and cognitive functions. It develops in a stepwise fashion:

  • Begins to form around 10 weeks of gestation
  • Completion of basic structure around 18–20 weeks
  • Continues to grow and mature throughout the third trimester

The CC is composed of four primary anatomical segments:

  • Rostrum
  • Genu
  • Body
  • Splenium

Postnatally, additional subregions such as the isthmus are identified.

Etiology of CC Anomalies

The authors describe the development of the CC as a complex neurodevelopmental process involving multiple signaling pathways and molecular cues, such as:

  • Semaphorin/Plexin/Neuropilin
  • Slit/Robo
  • Netrin/DCC/Unc5
  • Eph/Ephrin
  • Wnt/Ryk
  • FGF8/MAPK

Abnormal CC development can result from:

  • Genetic mutations
  • Chromosomal abnormalities
  • Monogenic syndromes
  • Teratogenic exposure (e.g., alcohol)
  • Vascular disruption
  • Infectious insults (e.g., TORCH, Zika virus)

Epidemiologically:

  • ACC prevalence in general population: ~1 in 4000–5000 live births
  • Prevalence in neurodevelopmental disorders: 230–600 per 100,000 individuals

Categories of Corpus Callosum Anomalies

The article identifies and explains five major categories:

  1. Complete agenesis of the corpus callosum (cACC)
    • Total absence of all four CC segments
    • Often identified via indirect ultrasound markers
  2. Partial agenesis of the corpus callosum (pACC)
    • One or more segments missing, commonly the splenium
    • May be due to developmental arrest between 12–18 weeks
  3. Hypoplasia
    • A complete CC with reduced thickness (<10th percentile or <2 SD)
    • May affect part or the entirety of the CC
  4. Hyperplasia
    • Abnormally thick CC
    • Rare; associated with syndromic or metabolic disorders
  5. Dysgenesis
    • Structurally abnormal CC with irregular morphology
    • Often poorly defined and used inconsistently in the literature

Sonographic Features and Diagnostic Approach

  1. Indirect Signs
  • Absence of cavum septi pellucidi (CSP)
  • Parallel orientation of lateral ventricles
  • Colpocephaly (dilated occipital horns)
  • “Tear drop” configuration of ventricles
  • Widened interhemispheric fissure
  1. Direct Visualization
  • Sagittal and coronal planes needed for full evaluation
  • Use of color Doppler to identify pericallosal artery
  • Transvaginal ultrasound increases resolution in early gestation
  1. Specific Sonographic Findings per Anomaly
  2. cACC
  • CSP absent
  • Third ventricle elevated
  • Lateral ventricles appear parallel
  • Absent pericallosal artery on Doppler
  • Confirmed by absence of hypoechoic band in midline sagittal view
  1. pACC
  • CSP may be present but altered
  • Posterior CC segments often missing
  • May present with colpocephaly
  • Ventricular measurements: length-to-width ratio of CSP <1.5 suggests pACC
  1. Hypoplasia
  • CC visualized but thin
  • Reference charts can assist in biometric assessment
  • May be associated with ventriculomegaly or other anomalies
  1. Hyperplasia
  • Rare
  • Thick, echogenic band visualized
  • Diagnostic criteria not standardized

Genetic Testing and Associations

  • Chromosomal anomalies account for ~10% of CC anomalies:
    • Trisomy 13, 18, 8
  • Pathogenic CNVs detectable via microarray: 5.7–6.9%
  • Monogenic syndromes: 20–35% of cases
    • Examples: Aicardi syndrome, Mowat-Wilson, Andermann, L1CAM-related disorders
  • Exome sequencing increasingly used to uncover de novo mutations and syndromic causes

Prognostic Outcomes

  1. Complete ACC
  • Isolated cACC: ~65–90% have normal or mildly delayed neurodevelopment
  • Association with:
    • Interhemispheric cysts
    • Dandy–Walker spectrum
    • Cortical malformations
  • Postnatal cognitive assessments often required between 10–20 years
  1. Partial ACC
  • Neurological outcomes vary
  • Literature suggests ~70–75% normal development in isolated cases
  • 15–25% risk of significant neurodevelopmental delay
  1. Hypoplasia and Dysgenesis
  • Outcomes less well studied
  • Higher likelihood of associated anomalies
  • Prognosis depends on extent and associated brain abnormalities

Counseling and Management Implications

  • Multidisciplinary approach recommended (geneticist, neurologist, fetal medicine specialist)
  • Emphasis on comprehensive prenatal imaging, ideally including fetal MRI when needed
  • Genetic counseling essential, especially when anomalies are complex or syndromic
  • Discuss the uncertainty of postnatal neurodevelopment, especially in isolated cases with subtle findings

Conclusion

This narrative review provides a structured summary of:

  • The types of corpus callosum anomalies encountered in prenatal ultrasound
  • How to detect and classify them using imaging criteria
  • Their genetic and syndromic associations
  • Their potential prognostic outcomes

The authors underscore that careful imaging, follow-up, and genetic testing are essential in managing pregnancies affected by CC anomalies. While some isolated forms of ACC are associated with favorable outcomes, others—especially those associated with dysgenesis, hypoplasia, or syndromic features—carry a risk of neurodevelopmental impairment. Accurate classification and counseling are therefore fundamental.

Introduction and Objectives

This article presents the results of a prospective, single-center, three-year study aiming to evaluate the performance of first-trimester ultrasound (FTUS) in detecting major central nervous system (CNS) anomalies, including early signs of corpus callosum anomalies. The study emphasizes the importance of CNS assessment during 11–13+6 weeks of gestation, a period traditionally focused on aneuploidy screening.

Objectives:

  • Assess the feasibility and diagnostic efficiency of a detailed CNS scan during the first trimester.
  • Describe first-trimester sonographic features of various CNS anomalies.
  • Determine the detection rate and specificity of this early screening.

Methods

  1. Study Design
  • Type: Prospective, observational study
  • Duration: 3 years (October 2019 – October 2022)
  • Centers: Two Romanian referral centers (Emergency County Hospital Craiova & Ginecho Clinic Craiova)
  1. Participants
  • Sample size: 1943 singleton pregnancies
  • Inclusion criteria:
    • Gestational age between 11 and 13 weeks + 6 days
    • Consent for participation and follow-up
  • Exclusion criteria:
    • Nonviable or multiple pregnancies
    • Patients lost to follow-up
  1. Ultrasound Protocol

A detailed FT anomaly scan (FTAS) was performed with focus on CNS structures:

  • Shape of calvaria
  • Presence and morphology of the falx cerebri
  • Lateral ventricles and choroid plexus
  • Third ventricle and aqueduct of Sylvius
  • Posterior brain complex: fourth ventricle (intracranial translucency, IT), brain stem (BS), BS/occipital bone ratio (BSOB), and cisterna magna (CM)
  • Spinal integrity and skin covering

Transabdominal ultrasound (TAUS) was used primarily; transvaginal ultrasound (TVUS) was performed when needed.

  1. Follow-up Strategy
  • Mid-trimester anomaly scan (18–22 weeks)
  • Third-trimester scan (if required)
  • Postnatal evaluation, including imaging or autopsy when indicated

Results

  1. CNS Anomalies Detected in First Trimester
  • Total CNS anomalies detected at FTAS: 17/1943 cases
    • Spina bifida with myelomeningocele: 3
    • Closed spina bifida: 1
    • Anencephaly/exencephaly: 3
    • Holoprosencephaly: 3
    • Cephalocele: 2
    • Hydrocephaly: 1
    • Dandy–Walker malformation: 2
    • Other posterior brain anomalies: 2
  1. Anomalies Detected Later (Second or Third Trimester)
  • Second trimester:
    • Corpus callosum agenesis (ACC): 2
    • ACC with Dandy–Walker malformation: 1
    • Cerebellar hypoplasia: 2
    • Signs of fetal infection (e.g., CMV): 3
  • Third trimester:
    • Vein of Galen aneurysm: 1
    • Massive cerebral hemorrhage: 1

These findings indicate that some CNS anomalies—particularly corpus callosum anomalies and posterior fossa malformations—may escape early detection and only manifest later in pregnancy.

Diagnostic Accuracy

  • Detection rate of FTAS for CNS anomalies: 72.7%
  • Specificity: 100%
  • Positive predictive value (PPV): 100%
  • Negative predictive value (NPV): 99.4%

These values reflect high diagnostic accuracy when a detailed CNS evaluation protocol is applied in the first trimester.

Sonographic Features of CC-Related and Midline Anomalies

While the first trimester scan was able to detect gross malformations (anencephaly, open spina bifida), midline anomalies such as agenesis of the corpus callosum (ACC) were not identified until the second trimester.

Indirect signs such as:

  • Absence or abnormal morphology of the third ventricle
  • Abnormal brainstem–cisterna magna relationship (BSOB)
  • Abnormal “crash sign” (brainstem distortion in spina bifida) were explored as early indicators but were not sufficient to detect ACC in the first trimester.

The authors highlight that complete evaluation of the corpus callosum is not feasible before 20 weeks due to its ongoing development.

Tables and Figures

  • Figure 1: CNS scanning protocol with annotated diagrams
  • Figure 2: Flowchart of included/excluded pregnancies
  • Table 1: Summary of first-trimester CNS anomalies detected (case-by-case)
  • Table 2: Second- and third-trimester anomalies diagnosed after negative FTAS
  • Table 3: Indications for repeat or transvaginal imaging
  • Figure 3–6: Sonographic images illustrating key anomalies

Limitations and Technical Factors

  • TAUS visualization sufficient in ~93% of cases
  • 7.05% required reevaluation or transvaginal scan due to:
    • Retroverted uterus
    • Maternal obesity (BMI > 24)
    • Uterine fibroids
    • Abdominal scarring
    • Suboptimal fetal position

Counseling and Clinical Implications

  • Early diagnosis of severe anomalies can reduce emotional burden and allow safer options for termination when desired
  • Limitations in detecting midline structures like the CC during FTAS must be communicated clearly to parents
  • Anomalies such as ACC, Dandy–Walker, and cerebellar hypoplasia may not be visible until later gestation
  • Serial evaluation remains essential, with mid-trimester scan serving as the key diagnostic window for corpus callosum

Conclusion

The authors conclude that:

  • First-trimester CNS evaluation using an extended protocol is both feasible and efficient
  • Most major anomalies (neural tube defects, anencephaly, holoprosencephaly) can be detected in the first trimester
  • Corpus callosum anomalies, however, typically require second-trimester or later assessment
  • Routine inclusion of CNS parameters in FTAS protocols is encouraged to improve early detection rates
  • Close follow-up, particularly in high-risk pregnancies or cases with subtle findings, is necessary to capture late-developing anomalies